1
|
Shaukat A, Marsh TL, Crockett SD, Syngal S, Bresalier RS, Brenner DE. Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal. Clin Gastroenterol Hepatol 2022; 20:2650-2652.e1. [PMID: 34547437 PMCID: PMC8934307 DOI: 10.1016/j.cgh.2021.09.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 08/18/2021] [Accepted: 09/14/2021] [Indexed: 02/07/2023]
Abstract
Prior studies have reported the prevalence of colorectal cancer (CRC) in average-risk screening population ages 50-75 to be 0.7%-1.0%.1,2 However, no estimates from studies enrolling individuals undergoing screening colonoscopy have been reported. The experience of ongoing studies enrolling average-risk individuals is that the prevalence rates are substantially lower. A 2020 study from a community-based cohort undergoing CRC screening with fecal immunochemical testing followed by diagnostic colonoscopy reported a CRC prevalence rate of 1.46 per 1000, or 0.15%.3 The aim of our study is to report the screen-detected prevalence of CRC and advanced neoplasia in average-risk asymptomatic individuals from selected academic and community medical centers in the United States, Canada, and Germany and describe associated risk factors.
Collapse
Affiliation(s)
- A Shaukat
- Division of Gastroenterology, Department of Medicine, NYU Langone Grossman School of Medicine, New York, New York.
| | - T L Marsh
- Department of Biostatistics, Fred Hutchinson Cancer Center, Seattle, Washington
| | - S D Crockett
- Department of Medicine, University of North Carolina, Chapel Hill, North Carolina
| | - S Syngal
- Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - R S Bresalier
- Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center, Houston, Texas
| | - D E Brenner
- Department of Medicine, University of Michigan, Ann Arbor, Michigan
| |
Collapse
|
2
|
Shen Y, Sen A, Turgeon DK, Ren J, Graifman G, Ruffin MT, Smith WL, Brenner DE, Djuric Z. Changes in Serum, Red Blood Cell, and Colonic Fatty Acids in a Personalized Omega-3 Fatty Acid Supplementation Trial. Nutr Cancer 2021; 74:565-578. [PMID: 33757398 DOI: 10.1080/01635581.2021.1903950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
This study evaluated changes in fatty acids from sera, red blood cells, and colonic biopsies from a phase Ib clinical trial of personalized ω-3 fatty acid dosing in 47 healthy volunteers. The trial aimed to reduce colonic prostaglandin E2 (PGE2), a pro-inflammatory product of arachidonic acid (AA) oxidation. The personalized doses ranged 2-10 grams/day (54% eicosapentaenoic acid, EPA, 24% other ω-3 fatty acids). In colon, increases in ω-3 highly unsaturated fatty acids (HUFA) and EPA:AA ratios each were correlated with decreases in PGE2. Changes in either colonic EPA:AA ratios or ω-3 HUFA were significantly correlated with changes in the same fatty acid measures in red blood cells or serum. The only blood-based measure significantly correlated with changes in colonic PGE2 was change in red blood cell ω-3 HUFA (ρ = -0.39), and the increase in red blood cell ω-3 HUFA was significantly greater in participants who had at least a median reduction in colonic PGE2 vs. those who did not. In summary, fatty acid changes in blood did reflect fatty acid changes in the colon, but additional factors will be needed for optimizing dosing models that seek to predict the anti-inflammatory effects of ω-3 fatty acids on the colon.
Collapse
Affiliation(s)
- Yifan Shen
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA.,Department of Nutritional Sciences, University of Michigan, Ann Arbor, Michigan, USA
| | - Ananda Sen
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA.,Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA
| | - D Kim Turgeon
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
| | - Jianwei Ren
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA
| | - Gillian Graifman
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA
| | - Mack T Ruffin
- Department of Family and Community Medicine, Penn State, Hershey, Pennsylvania, USA
| | - William L Smith
- Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, USA
| | - Dean E Brenner
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.,Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA
| | - Zora Djuric
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.,Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA.,Department of Nutritional Sciences, University of Michigan, Ann Arbor, Michigan, USA
| |
Collapse
|
3
|
Sen A, Zhao L, Djuric Z, Turgeon DK, Ruffin MT, Smith WL, Brenner DE, Normolle DP. An Adaptive Bayesian Design for Personalized Dosing in a Cancer Prevention Trial. Am J Prev Med 2020; 59:e167-e173. [PMID: 32951684 PMCID: PMC7531353 DOI: 10.1016/j.amepre.2020.04.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Revised: 04/22/2020] [Accepted: 04/24/2020] [Indexed: 01/07/2023]
Abstract
INTRODUCTION In biomarker-driven clinical trials, translational strategies typically involve moving findings from animal experiments to human trials. Typically, the translation is static, using a fixed model derived from animal experiments for the duration of the trial. Bayesian designs, capable of incorporating information external to the experiment, provide a dynamic translational strategy. This article demonstrates an example of such a dynamic Bayesian strategy in a clinical trial. METHODS This study explored the effect of a personalized dose of fish oil for reducing prostaglandin E2, an inflammatory marker linked to colorectal cancer. A Bayesian design was implemented for the dose-finding algorithm that adaptively updated a dose-response model derived from a previously completed animal study during the clinical trial. In the initial stages of the trial, the dose-response model parameters were estimated from the rodent data. The model was updated following a Bayesian algorithm after data on every 10‒15 subjects were obtained until the model stabilized. Subjects were enrolled in the study between 2013 and 2015, and the data analysis was carried out in 2016. RESULTS The 3 dosing models were used for groups of 16, 15, and 15 subjects. The mean target dose significantly decreased from 6.63 g/day (Model 1) to 4.06 g/day (Model 3) (p=0.001). Compared with the static strategy of dosing with a single model, the dynamic modeling reduced the dose significantly by about 1.38 g/day on average. CONCLUSIONS A Bayesian design was effective in adaptively revising the dosing algorithm, resulting in a lower pill burden. TRIAL REGISTRATION This study is registered at www.clinicaltrials.gov NCT01860352.
Collapse
Affiliation(s)
- Ananda Sen
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Department of Biostatistics, University of Michigan Medical School, Ann Arbor, Michigan.
| | - Lili Zhao
- Department of Biostatistics, University of Michigan Medical School, Ann Arbor, Michigan
| | - Zora Djuric
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - D Kim Turgeon
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Mack T Ruffin
- Department of Family and Community Medicine, Penn State Hershey Medical Center, Hershey, Pennsylvania
| | - William L Smith
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan
| | - Daniel P Normolle
- Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania
| |
Collapse
|
4
|
Colacino J, Djuric Z, Brenner DE. How Does Obesity Drive Human Carcinogenesis? Challenges in Dissecting the Mechanisms of Adipose-Epithelial Signaling. Cancer Prev Res (Phila) 2020; 13:803-806. [PMID: 32839206 DOI: 10.1158/1940-6207.capr-20-0367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 08/03/2020] [Accepted: 08/05/2020] [Indexed: 11/16/2022]
Abstract
Obesity is the second leading environmental association with cancer risk; yet, the mechanisms by which obesity drives carcinogenesis are poorly understood. The paper published in this issue of Cancer Prevention Research by Holowatyj and colleagues explores the mechanisms of human visceral adipose-epithelial signaling using samples collected at surgery in patients with invasive colorectal cancer. They identify pathway intermediates potentially involved in the regulation of fibrosis, inflammation, glycosis, and epithelial-mesenchymal transition in neoplastic tissue. 'Omics-based profiling of perioperative human biosamples has potential for inherent biases (preoperative and intraoperative drug therapies, hydration, dynamics, inflammatory response to surgical intervention) and appropriate control samples are difficult to identify and collect. Solutions to this dilemma may include strategies to identify patients undergoing similar surgical procedures but who are without neoplasms, for example, patients with gynecologic problems, abdominal exploration for suspected appendicitis, symptoms or resection of gall stone disease or undergoing bariatric surgery. As the field continues to grow, studies incorporating robust statistical analyses, validation of findings in diverse cohorts, and public data sharing will be essential to identify biological pathways linking obesity and carcinogenesis to be further interrogated using focused, hypothesis-driven approaches.See related article by Holowatyj et al., p. 817.
Collapse
Affiliation(s)
- Justin Colacino
- Department of Environmental Health Sciences and Department of Nutrition Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan
| | - Zora Djuric
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Dean E Brenner
- Division of Hematology-Oncology, Department of Internal Medicine and Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan.
| |
Collapse
|
5
|
Djuric Z, Bassis CM, Plegue MA, Sen A, Turgeon DK, Herman K, Young VB, Brenner DE, Ruffin MT. Increases in Colonic Bacterial Diversity after ω-3 Fatty Acid Supplementation Predict Decreased Colonic Prostaglandin E2 Concentrations in Healthy Adults. J Nutr 2019; 149:1170-1179. [PMID: 31051496 PMCID: PMC6602899 DOI: 10.1093/jn/nxy255] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2018] [Revised: 08/01/2018] [Accepted: 09/10/2018] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND The intestinal microbiome is an important determinant of inflammatory balance in the colon that may affect response to dietary agents. OBJECTIVE This is a secondary analysis of a clinical trial, the Fish Oil Study, to determine whether interindividual differences in colonic bacteria are associated with variability in the reduction of colonic prostaglandin E2 (PGE2) concentrations after personalized supplementation with ω-3 (n-3) fatty acids. METHODS Forty-seven healthy adults (17 men, 30 women, ages 26-75 y) provided biopsy samples of colonic mucosa and luminal stool brushings before and after personalized ω-3 fatty acid supplementation that was based on blood fatty acid responses. Samples were analyzed using 16S ribosomal RNA sequencing. The data analyses focused on changes in bacterial community diversity. Linear regression was used to evaluate factors that predict a reduction in colonic PGE2. RESULTS At baseline, increased bacterial diversity, as measured by the Shannon and Inverse Simpson indexes in both biopsy and luminal brushing samples, was positively correlated with dietary fiber intakes and negatively correlated with fat intakes. Dietary supplementation with ω-3 fatty acids increased the Yue and Clayton community dis-similarity index between the microbiome in luminal brushings and colon biopsy samples post-supplementation (P = 0.015). In addition, there was a small group of individuals with relatively high Prevotella abundance who were resistant to the anti-inflammatory effects of ω-3 fatty acid supplementation. In linear regression analyses, increases in diversity of the bacteria in the luminal brushing samples, but not in the biopsy samples, were significant predictors of lower colonic PGE2 concentrations post-supplementation in models that included baseline PGE2, baseline body mass index, and changes in colonic eicosapentaenoic acid-to-arachidonic acid ratios. The changes in bacterial diversity contributed to 6-8% of the interindividual variance in change in colonic PGE2 (P = 0.001). CONCLUSIONS Dietary supplementation with ω-3 fatty acids had little effect on intestinal bacteria in healthy humans; however, an increase in diversity in the luminal brushings significantly predicted reductions in colonic PGE2. This trial was registered at www.clinicaltrials.gov as NCT01860352.
Collapse
Affiliation(s)
- Zora Djuric
- Departments of Family Medicine
- Nutritional Sciences
| | | | | | - Ananda Sen
- Departments of Family Medicine
- Biostatistics
| | | | | | | | - Dean E Brenner
- Internal Medicine
- Pharmacology, University of Michigan, Ann Arbor, MI
| | - Mack T Ruffin
- Family and Community Medicine, Penn State Health, Milton S Hershey Medical Center, Hershey, PA
| |
Collapse
|
6
|
Hill EM, Esper RM, Sen A, Simon BR, Aslam MN, Jiang Y, Dame MK, McClintock SD, Colacino JA, Djuric Z, Wicha MS, Smith WL, Brenner DE. Dietary polyunsaturated fatty acids modulate adipose secretome and is associated with changes in mammary epithelial stem cell self-renewal. J Nutr Biochem 2019; 71:45-53. [PMID: 31272031 DOI: 10.1016/j.jnutbio.2019.05.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Revised: 05/09/2019] [Accepted: 05/10/2019] [Indexed: 02/07/2023]
Abstract
Chronic low-grade adipose inflammation, characterized by aberrant adipokine production and pro-inflammatory macrophage activation/polarization is associated with increased risk of breast cancer. Adipocyte fatty acid composition is influenced by dietary availability and may regulate adipokine secretion and adipose inflammation. After feeding F344 rats for 20 weeks with a Western diet or a fish oil-supplemented diet, we cultured primary rat adipose tissue in a three-dimensional explant culture and collected the conditioned medium. The rat adipose tissue secretome was assayed using the Proteome Profiler Cytokine XL Array, and adipose tissue macrophage polarization (M1/M2 ratio) was assessed using the iNOS/ARG1 ratio. We then assessed the adipokine's effects upon stem cell self-renewal using primary human mammospheres from normal breast mammoplasty tissue. Adipose from rats fed the fish oil diet had an ω-3:ω-6 fatty acid ratio of 0.28 compared to 0.04 in Western diet rats. The adipokine profile from the fish oil-fed rats was shifted toward adipokines associated with reduced inflammation compared to the rats fed the Western diet. The M1/M2 macrophage ratio decreased by 50% in adipose of fish oil-fed rats compared to that from rats fed the Western diet. Conditioned media from rats fed the high ω-6 Western diet increased stem cell self-renewal by 62%±9% (X¯%±SD) above baseline compared to only an 11%±11% increase with the fish oil rat adipose. Modulating the adipokine secretome with dietary interventions therefore may alter stromal-epithelial signaling that plays a role in controlling mammary stem cell self-renewal.
Collapse
Affiliation(s)
- Evan M Hill
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA
| | - Raymond M Esper
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Ananda Sen
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Becky R Simon
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Muhammad N Aslam
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Yan Jiang
- MD Anderson Cancer Center, Houston, TX, USA
| | - Michael K Dame
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Shannon D McClintock
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Justin A Colacino
- Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA
| | - Zora Djuric
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA
| | - Max S Wicha
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
| | - William L Smith
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.
| |
Collapse
|
7
|
Wilson MJ, Sen A, Bridges D, Turgeon DK, Brenner DE, Smith WL, Ruffin MT, Djuric Z. Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E 2 concentrations after dietary supplementation with ω-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2018; 139:14-19. [PMID: 30471768 PMCID: PMC6343141 DOI: 10.1016/j.plefa.2018.11.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2018] [Revised: 09/13/2018] [Accepted: 11/01/2018] [Indexed: 12/16/2022]
Abstract
This study evaluated whether mRNA expression of major genes regulating formation of prostaglandin (PG)E2 in the colon and colonic fatty acid concentrations are associated with the reduction in colonic mucosal PGE2 after dietary supplementation with omega-3 (ω-3) fatty acids. Supplementation with ω-3 fatty acids was done for 12 weeks using personalized dosing that was expected to reduce colonic PGE2 by 50%. In stepwise linear regression models, the ω-3 fatty acid dose and baseline BMI explained 16.1% of the inter-individual variability in the fold change of colonic PGE2 post-supplementation. Increases in mRNA gene expression after supplementation were, however, modest and were not associated with changes in PGE2. When baseline expression of PTGS1, PTGS2 and HPGD genes was included in the linear regression model containing dose and BMI, only PTGS2, the gene coding for the inducible form cyclooxygenase, was a significant predictor. Higher relative expression of PTGS2 predicted greater decreases in colonic PGE2, accounting for an additional 13.6% of the inter-individual variance. In the final step of the regression model, greater decreases in total colonic fatty acid concentrations predicted greater decreases in colonic PGE2, contributing to an additional 18.7% of the variance. Overall, baseline BMI, baseline expression of PTGS2 and changes in colonic total fatty acids together accounted for 48% of the inter-individual variability in the change in colonic PGE2. This is consistent with biochemical data showing that fatty acids which are not substrates for cyclooxygenases can activate cyclooxygenase-2 allosterically. Further clinical trials are needed to elucidate the factors that regulate the fatty acid milieu of the human colon and how this interacts with key lipid metabolizing enzymes. Given the central role of PGE2 in colon carcinogenesis, these pathways may also impact on colon cancer prevention by other dietary and pharmacological approaches.
Collapse
Affiliation(s)
- Matthew J Wilson
- Department of Nutritional Sciences, University of Michigan, Ann Arbor, MI
| | - Ananda Sen
- Department of Family Medicine, University of Michigan, Ann Arbor, MI; Department of Biostatistics, University of Michigan, Ann Arbor, MI
| | - Dave Bridges
- Department of Nutritional Sciences, University of Michigan, Ann Arbor, MI
| | - D Kim Turgeon
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI; Department of Pharmacology, University of Michigan, Ann Arbor, MI
| | - William L Smith
- Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109
| | - Mack T Ruffin
- Department of Family and Community Medicine, Penn State University, Hershey, PA
| | - Zora Djuric
- Department of Nutritional Sciences, University of Michigan, Ann Arbor, MI; Department of Family Medicine, University of Michigan, Ann Arbor, MI.
| |
Collapse
|
8
|
Cooper GS, Markowitz SD, Chen Z, Tuck M, Willis JE, Berger BM, Brenner DE, Li L. Performance of multitarget stool DNA testing in African American patients. Cancer 2018; 124:3876-3880. [PMID: 30193399 DOI: 10.1002/cncr.31660] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 06/19/2018] [Accepted: 06/21/2018] [Indexed: 01/16/2023]
Abstract
BACKGROUND Multitarget stool DNA (mt-sDNA) is an approved method for colon cancer screening that is especially relevant for patients who cannot undergo colonoscopy. Although the test performance has been evaluated in a large clinical trial, it was limited to a predominantly white population. Given differences in the epidemiology and biology of colon cancer in African American individuals, the authors sought to compare the performance of mt-sDNA between racial groups. METHODS The authors prospectively identified patients aged ≥40 years who were referred for colonoscopy at an academic medical center and 2 satellite facilities. Prior to the colonoscopy, the authors collected stool for mt-sDNA and fecal immunochemical testing (FIT). They compared the sensitivity, specificity, and receiver operating characteristic curve between African American and white patients for the detection of advanced lesions or any adenoma. RESULTS A total of 760 patients were included, 34.9% of whom were African American. The prevalence of any adenoma (38.9% for African American patients and 33.9% for white patients) and that for advanced lesions (6.8% and 6.7%, respectively) were similar between groups. The overall sensitivities of mt-sDNA for the detection of advanced lesions and any adenoma were 43% and 19%, respectively, and the specificities were 91% and 93%, respectively. In general, mt-sDNA was more sensitive and less specific than FIT. When stratified by race, the sensitivity, specificity, and receiver operating characteristic curve area were similar between African American and white patients for both mt-sDNA and FIT. CONCLUSIONS Test performance characteristics of mt-sDNA were comparable in African American and white patients. Given the lower uptake of colonoscopy in African American individuals, mt-sDNA may offer a promising screening alternative in this patient population.
Collapse
Affiliation(s)
- Gregory S Cooper
- Division of Gastroenterology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.,Case Comprehensive Cancer Center, Cleveland, Ohio
| | - Sanford D Markowitz
- Case Comprehensive Cancer Center, Cleveland, Ohio.,Division of Hematology-Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio
| | - Zhengyi Chen
- Department of Family Medicine and Community Health, University Hospitals Cleveland Medical Center, Cleveland, Ohio
| | - Missy Tuck
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
| | - Joseph E Willis
- Case Comprehensive Cancer Center, Cleveland, Ohio.,Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio
| | | | - Dean E Brenner
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
| | - Li Li
- Case Comprehensive Cancer Center, Cleveland, Ohio.,Department of Family Medicine and Community Health, University Hospitals Cleveland Medical Center, Cleveland, Ohio
| |
Collapse
|
9
|
Cooper GS, Markowitz SD, Chen Z, Tuck M, Willis JE, Berger BM, Brenner DE, Li L. Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 2018; 63. [PMID: 29516325 PMCID: PMC5960589 DOI: 10.1007/s10620-018-5001-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND There is uncertainty as to the appropriate follow-up of patients who test positive on multimarker stool DNA (sDNA) testing and have a colonoscopy without neoplasia. AIMS To determine the prevalence of missed colonic or occult upper gastrointestinal neoplasia in patients with an apparent false positive sDNA. METHODS We prospectively identified 30 patients who tested positive with a commercially available sDNA followed by colonoscopy without neoplastic lesions. Patients were invited to undergo repeat sDNA at 11-29 months after the initial test followed by repeat colonoscopy and upper endoscopy. We determined the presence of neoplastic lesions on repeat evaluation stratified by results of repeat sDNA. RESULTS Twelve patients were restudied. Seven patients had a negative second sDNA test and a normal second colonoscopy and upper endoscopy. In contrast, 5 of 12 subjects had a persistently positive second sDNA test, and 3 had positive findings, including a 3-cm sessile transverse colon adenoma with high-grade dysplasia, a 2-cm right colon sessile serrated adenoma with dysplasia, and a nonadvanced colon adenoma (p = 0.045). These corresponded to a positive predictive value of 0.60 (95% CI 0.17-1.00) and a negative predictive value of 1.00 (95% CI 1.00-1.00) for the second sDNA test. In addition, the medical records of all 30 subjects with apparent false positive testing were reviewed and no documented cases of malignant tumors were recorded. CONCLUSIONS Repeat positive sDNA testing may identify a subset of patients with missed or occult colorectal neoplasia after negative colonoscopy for an initially positive sDNA. High-quality colonoscopy with careful attention to the right colon in patients with positive sDNA is critically important and may avoid false negative colonoscopy.
Collapse
|
10
|
Dame MK, Attili D, McClintock SD, Dedhia PH, Ouillette P, Hardt O, Chin AM, Xue X, Laliberte J, Katz EL, Newsome GM, Hill DR, Miller AJ, Tsai YH, Agorku D, Altheim CH, Bosio A, Simon B, Samuelson LC, Stoerker JA, Appelman HD, Varani J, Wicha MS, Brenner DE, Shah YM, Spence JR, Colacino JA. Identification, isolation and characterization of human LGR5-positive colon adenoma cells. Development 2018; 145:dev.153049. [PMID: 29467240 DOI: 10.1242/dev.153049] [Citation(s) in RCA: 53] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Accepted: 02/06/2018] [Indexed: 01/02/2023]
Abstract
The intestine is maintained by stem cells located at the base of crypts and distinguished by the expression of LGR5. Genetically engineered mouse models have provided a wealth of information about intestinal stem cells, whereas less is known about human intestinal stem cells owing to difficulty detecting and isolating these cells. We established an organoid repository from patient-derived adenomas, adenocarcinomas and normal colon, which we analyzed for variants in 71 colorectal cancer (CRC)-associated genes. Normal and neoplastic colon tissue organoids were analyzed by immunohistochemistry and fluorescent-activated cell sorting for LGR5. LGR5-positive cells were isolated from four adenoma organoid lines and were subjected to RNA sequencing. We found that LGR5 expression in the epithelium and stroma was associated with tumor stage, and by integrating functional experiments with LGR5-sorted cell RNA sequencing data from adenoma and normal organoids, we found correlations between LGR5 and CRC-specific genes, including dickkopf WNT signaling pathway inhibitor 4 (DKK4) and SPARC-related modular calcium binding 2 (SMOC2). Collectively, this work provides resources, methods and new markers to isolate and study stem cells in human tissue homeostasis and carcinogenesis.
Collapse
Affiliation(s)
- Michael K Dame
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Durga Attili
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
| | | | - Priya H Dedhia
- Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA
| | - Peter Ouillette
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Olaf Hardt
- Miltenyi Biotec GmbH, Bergisch Gladbach, 51429, Germany
| | - Alana M Chin
- Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Xiang Xue
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Julie Laliberte
- Department of Research and Development, Progenity, Inc., Ann Arbor, MI 48109, USA
| | - Erica L Katz
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Gina M Newsome
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - David R Hill
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Alyssa J Miller
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.,Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI 48109, USA
| | - Yu-Hwai Tsai
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - David Agorku
- Miltenyi Biotec GmbH, Bergisch Gladbach, 51429, Germany
| | - Christopher H Altheim
- Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Andreas Bosio
- Miltenyi Biotec GmbH, Bergisch Gladbach, 51429, Germany
| | - Becky Simon
- BioCentury Publications, Redwood City, CA 94065, USA
| | - Linda C Samuelson
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.,Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Jay A Stoerker
- Department of Research and Development, Progenity, Inc., Ann Arbor, MI 48109, USA
| | - Henry D Appelman
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
| | - James Varani
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Max S Wicha
- Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Dean E Brenner
- Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.,Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Yatrik M Shah
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.,Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Jason R Spence
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.,Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Justin A Colacino
- Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA .,Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
| |
Collapse
|
11
|
Rho JH, Ladd JJ, Li CI, Potter JD, Zhang Y, Shelley D, Shibata D, Coppola D, Yamada H, Toyoda H, Tada T, Kumada T, Brenner DE, Hanash SM, Lampe PD. Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 2018; 67:473-484. [PMID: 27821646 PMCID: PMC5420499 DOI: 10.1136/gutjnl-2016-312794] [Citation(s) in RCA: 48] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/05/2016] [Revised: 10/04/2016] [Accepted: 10/18/2016] [Indexed: 12/22/2022]
Abstract
OBJECTIVE To discover and confirm blood-based colon cancer early-detection markers. DESIGN We created a high-density antibody microarray to detect differences in protein levels in plasma from individuals diagnosed with colon cancer <3 years after blood was drawn (ie, prediagnostic) and cancer-free, matched controls. Potential markers were tested on plasma samples from people diagnosed with adenoma or cancer, compared with controls. Components of an optimal 5-marker panel were tested via immunoblotting using a third sample set, Luminex assay in a large fourth sample set and immunohistochemistry (IHC) on tissue microarrays. RESULTS In the prediagnostic samples, we found 78 significantly (t-test) increased proteins, 32 of which were confirmed in the diagnostic samples. From these 32, optimal 4-marker panels of BAG family molecular chaperone regulator 4 (BAG4), interleukin-6 receptor subunit beta (IL6ST), von Willebrand factor (VWF) and CD44 or epidermal growth factor receptor (EGFR) were established. Each panel member and the panels also showed increases in the diagnostic adenoma and cancer samples in independent third and fourth sample sets via immunoblot and Luminex, respectively. IHC results showed increased levels of BAG4, IL6ST and CD44 in adenoma and cancer tissues. Inclusion of EGFR and CD44 sialyl Lewis-A and Lewis-X content increased the panel performance. The protein/glycoprotein panel was statistically significantly higher in colon cancer samples, characterised by a range of area under the curves from 0.90 (95% CI 0.82 to 0.98) to 0.86 (95% CI 0.83 to 0.88), for the larger second and fourth sets, respectively. CONCLUSIONS A panel including BAG4, IL6ST, VWF, EGFR and CD44 protein/glycomics performed well for detection of early stages of colon cancer and should be further examined in larger studies.
Collapse
Affiliation(s)
- Jung-hyun Rho
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA,Human Biology Divisions, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
| | - Jon J. Ladd
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA,Human Biology Divisions, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
| | - Christopher I. Li
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
| | - John D. Potter
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA,School of Public Health, University of Washington, Seattle, Washington, United States of America; Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Yuzheng Zhang
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
| | - David Shelley
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA,Human Biology Divisions, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
| | - David Shibata
- University of Tennessee Health Science Center, Memphis, TN
| | | | | | - Hidenori Toyoda
- Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan
| | - Toshifumi Tada
- Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan
| | - Takashi Kumada
- Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan
| | - Dean E. Brenner
- Great Lakes New England (GLNE) Clinical Validation Center of EDRN, University of Michigan Medical Center, Ann Arbor, MI 48109, USA; VA Medical Center, Ann Arbor, MI 48105, USA
| | - Samir M. Hanash
- Department of Clinical Cancer Prevention, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, 6767 Bertner Street, Houston, TX 77030, USA
| | - Paul D. Lampe
- Translational Research Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA,Human Biology Divisions, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
| |
Collapse
|
12
|
Djuric Z, Turgeon DK, Sen A, Ren J, Herman K, Ramaswamy D, Zhao L, Ruffin MT, Normolle DP, Smith WL, Brenner DE. The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E 2 in the Colonic Mucosa Is Attenuated in Obesity. Cancer Prev Res (Phila) 2017; 10:729-737. [PMID: 29133307 DOI: 10.1158/1940-6207.capr-17-0091] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 07/12/2017] [Accepted: 10/02/2017] [Indexed: 12/20/2022]
Abstract
This clinical trial developed a personalized dosing model for reducing prostaglandin E2 (PGE2) in colonic mucosa using ω-3 fatty acid supplementation. The model utilized serum eicosapentaenoic acid (EPA, ω-3):arachidonic acid (AA, ω-6) ratios as biomarkers of colonic mucosal PGE2 concentration. Normal human volunteers were given low and high ω-3 fatty acid test doses for 2 weeks. This established a slope and intercept of the line for dose versus serum EPA:AA ratio in each individual. The slope and intercept was utilized to calculate a personalized target dose that was given for 12 weeks. This target dose was calculated on the basis of a model, initially derived from lean rodents, showing a log-linear relationship between serum EPA:AA ratios and colonic mucosal PGE2 reduction. Bayesian methods allowed addition of human data to the rodent model as the trial progressed. The dosing model aimed to achieve a serum EPA:AA ratio that is associated with a 50% reduction in colonic PGE2 Mean colonic mucosal PGE2 concentrations were 6.55 ng/mg protein (SD, 5.78) before any supplementation and 3.59 ng/mg protein (SD, 3.29) after 12 weeks of target dosing. In secondary analyses, the decreases in PGE2 were significantly attenuated in overweight and obese participants. This occurred despite a higher target dose for the obese versus normal weight participants, as generated by the pharmacodynamic predictive model. Large decreases also were observed in 12-hydroxyicosatetraenoic acids, and PGE3 increased substantially. Future biomarker-driven dosing models for cancer prevention therefore should consider energy balance as well as overall eicosanoid homeostasis in normal tissue. Cancer Prev Res; 10(12); 729-37. ©2017 AACR.
Collapse
Affiliation(s)
- Zora Djuric
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
| | - D Kim Turgeon
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Ananda Sen
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.,Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan
| | - Jianwei Ren
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Kirk Herman
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Devon Ramaswamy
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Lili Zhao
- Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan
| | - Mack T Ruffin
- Department of Family and Community Medicine, Penn State Hershey Medical Center, Hershey, Pennsylvania
| | - Daniel P Normolle
- Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania
| | - William L Smith
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.,Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan
| |
Collapse
|
13
|
Hong SH, Misek DE, Wang H, Puravs E, Hinderer R, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM. Identification of a Specific Vimentin isoform that Induces an Antibody Response in Pancreatic Cancer. Biomark Insights 2017. [DOI: 10.1177/117727190600100006] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Pancreatic cancer has a poor prognosis, in part due to lack of early detection. The identification of circulating tumor antigens or their related autoantibodies provides a means for early cancer diagnosis. We have used a proteomic approach to identify proteins that commonly induce a humoral response in pancreatic cancer. Proteins from a pancreatic adenocarcinoma cell line (Panc-1) were subjected to two-dimensional PAGE, followed by Western blot analysis in which individual sera were tested for autoantibodies. Sera from 36 newly diagnosed patients with pancreatic cancer, 18 patients with chronic pancreatitis and 15 healthy subjects were analyzed. Autoantibodies were detected against a protein identified by mass spectrometry as vimentin, in sera from 16/36 patients with pancreatic cancer (44.4%). Only one of 18 chronic pancreatitis patients and none of the healthy controls exhibited reactivity against this vimentin isoform. Interestingly, none of several other isoforms of vimentin detectable in 2-D gels exhibited reactivity with patient sera. Vimentin protein expression levels were investigated by comparing the integrated intensity of spots visualized in 2-D PAGE gels of various cancers. Pancreatic tumor tissues showed greater than a 3-fold higher expression of total vimentin protein than did the lung, colon, and ovarian tumors that were analyzed. The specific antigenic isoform was found at 5–10 fold higher levels. The detection of autoantibodies to this specific isoform of vimentin may have utility for the early diagnosis of pancreatic cancer.
Collapse
Affiliation(s)
- Su-Hyung Hong
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - David E. Misek
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Hong Wang
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Eric Puravs
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Robert Hinderer
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Thomas J. Giordano
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Joel K. Greenson
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Dean E. Brenner
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Diane M. Simeone
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Craig D. Logsdon
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| | - Samir M. Hanash
- Departments of Pediatrics (SHH, DEM, HW, EP, RH, SMH), Pathology (TJG and JKG), Physiology (CDL), Surgery (DMS) and Internal Medicine (DEB), University of Michigan Medical School, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109 and the Department of Dental Microbiology (SHH), School of Dentistry, Kyungpook National University, 101 Dongin-Dong, Jung-Gu, Daegu, 700-422, South Korea
| |
Collapse
|
14
|
Aslam MN, Sridhar N, Nadeem M, Simon BR, Ren J, Sen A, Varani J, Smith WL, Djuric Z, Brenner DE. Abstract 5256: Intracellular lipid droplet quantity as a biomarker for obesity associated resistance to omega-3 fatty acid colon cancer prevention. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-5256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Rationale: Obesity induces resistance to Omega-3 (ω-3) FA anticarcinogenesis effect. Obesity associated excessive fatty acid intracellular concentration results in excess triglycerides stored as intracellular lipid droplets, saturated acyl-co-A transport of FA to triglycerides resulting in excess substrate for cyclooxygenase metabolism with increased formation of PGE2 and other inflammatory eicosanoids.
Methods: Five weeks old male F344 rats were randomized equally into two diet groups. One cohort fed a western diet of ω-6 fatty acids (EPA:ω6 ratio of 0) and other fed an ω-3 fatty acid supplemented diet (EPA:ω6 ratio of 0.4). One half from each diet group were further treated with azoxymethane/dextran sulfate sodium (AOM/DSS) and then euthanized at 21 weeks after the carcinogen induction. Snap frozen colon tissue were assayed for Prostaglandins and fatty acids. OCT fixed colonic tissue stained with oil red O (ORO) to detect lipid droplets which were quantified using Aperio image analysis. From the second set, rat colons were opened longitudinally and fixed in 10% Formalin. Tumors were identified and enumerated using stereomicroscope to get tumor count, incidence and volume. These tissue were subjected to hematoxylin & eosin staining for histological evaluation of colonic tumors.
Results: The ω-3 FA diet significantly increased the percent of eicosapentaenoic acid (EPA) in total fatty acids in both untreated and AOM/DSS-treated rats. EPA in the colonic tissue was increased with ω-3 diet as compared to ω-6 from 1.4±0.8 to 2.6±1.0* in untreated rats and from 1.3±1.3 to 3.3±1.7* in AOM/DSS-treated rats (*p<0.005). PGE2 increased with AOM/DSS treatment. The ω-3 diet decreased PGE2 in colonic mucosa of untreated rats from 132±64 in ω-6 to 78±17 in ω-3 and 150±74 in ω-6 to 92±43 in ω-3 with AOM/DSS treatment. Most tumors were found in the distal colon (DC) with ω-3 diet significantly reducing the number of tumors (p value=0.0011). The ω-3 diet significantly reduced colonic adenoma volume and multiplicity. When tumors were stratified by size and location, there was a significant effect of diet in the DC, with ω-3 diet reducing the number of tumors in the 1-3mm range (p value=0.0018), 3-5mm (p value=0.0041) and >5mm (p value=0.0055). ω-3 also reduced the number of 3-5mm size tumors in the cecum (p value=0.0377). On preliminary quantification of lipid droplets, there was a reduction in the positive pixels divided by the total pixels of ORO stained colonic tissue of ω-3 rats (0.004 ±0.01 as compared to 0.013±0.07 in ω-6 rats; p value=0.0121)
Conclusions: Dietary ω-3 supplementation that increases the EPA:AA ratio in colonic tissue phospholipids reduces excess intracellular FA concentrations reflected by a reduction in size and number of lipid droplets. Lipid droplet number and size may be useful as a biomarker for effective reduction of obesity associated inflammation and carcinogenesis risk.
Citation Format: Muhammad N. Aslam, Nithya Sridhar, Maheen Nadeem, Becky R. Simon, Jianwei Ren, Ananda Sen, James Varani, William L. Smith, Zora Djuric, Dean E. Brenner. Intracellular lipid droplet quantity as a biomarker for obesity associated resistance to omega-3 fatty acid colon cancer prevention [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5256. doi:10.1158/1538-7445.AM2017-5256
Collapse
|
15
|
Mahran R, Shu P, Sun D, Brenner DE. Abstract 5257: Cellular pharmacology of curcumin cellular pharmacology of curcumin±piperine. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-5257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Rationale: Prior reports have suggested that piperine, the major alkaloid product derived from black and long pepper, enhances curcumin’s cancer preventive efficacy in vitro and in vivo by an intracellular pharmacokinetic interaction; yet, no previous studies have explored the pharmacokinetic interactions between curcumin and piperine.
Methods: We incubated non-transformed breast cell line MCF10A and breast cancer SUM149 cell line with different concentrations of curcumin, piperine or curcumin + piperine to assess cell viability using a MTT assay. For curcumin and piperine uptake assays, we incubated MCF10A, SUM149 and MCF7 breast cells with either 5 µM curcumin or 5 µM curcumin + 5 µM piperine for 0.5, 1, 4,6,8,12 and 24 h, or with 15 µM curcumin or 15 µM curcumin + 10 µM piperine for 0.17, 0.5, 1,2 and 4h. Media and cell lysates were extracted for assay of intracellular curcumin and piperine by LC-MS/MS. ALDH+ , ALDH-CD44+24- cells were collected via FACS, incubated with 15 µM curcumin or 15 µM curcumin + 10 µM piperine for 1 hour. Cell lysates and media were assayed for curcumin, curcumin degradation and metabolic products and quantified using LC-MS/MS.
Results: 90.7±0.06% and 34.8 ±0.002% of cells were viable after incubating MCF10A and SUM149 cells respectively with 25 µM curcumin compared to DMSO control. Incubation with 10 µM Piperine enhanced the antiproliferative effect of 15 µM curcumin by 33.6±0.015% (P< 0.05) and 16.3±0.003% (P<0.05) in SUM149 and MCF10A cells respectively. We found no significant increase of intracellular concentration of curcumin when coincubated with piperine in the MCF10A, MCF7 and SUM149 cells or in the ALDH+ and the ALDH- CD44+CD24- SUM149 cells. Curcumin intracellular concentration was 166.7±22 and 151.5±24 ng/mg protein in ALDH+ cells for curcumin alone or curcumin + piperine respectively and 130±25.4 and 135±27.4 ng/mg protein in ALDH- CD44+CD24- for curcumin alone or curcumin + piperine respectively in SUM149 cell line. Curcumin uptake was lower in MCF10A cells than SUM149 cells. The intracellular curcumin concentration after 1 hour incubation with 5 µM curcumin was 11.8±0.8 and 68.1±11.2 in MCF10A and SUM149 cells respectively. Tetrahydrocurcumin and curcumin sulfate conjugates were the major metabolites detected in MCF7 and SUM149 cell lines. Curcumin sulfate is detectable in the media as early as 0.5h, it increases from 1.36±0.06 and 1.43±0.05 after 0.5h to 22.6±0.53 and 23±2.2 ng/ml after 4 h for curcumin and curcumin + piperine respectively in the media of ALDH-CD44+Cd24- SUM149 cells.
Conclusions: We find no significant difference in intracellular curcumin concentration between cells treated with curcumin alone or curcumin + piperine after incubation times up to 24 hr. The additive cellular toxicity effects observed with piperine + curcumin is not pharmacokinetic (associated with efflux pump inhibition) but rather pharmacodynamic due to piperine’s independent anti-proliferative effects.
Citation Format: Rama Mahran, Pan Shu, Duxin Sun, Dean E. Brenner. Cellular pharmacology of curcumin cellular pharmacology of curcumin±piperine [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5257. doi:10.1158/1538-7445.AM2017-5257
Collapse
Affiliation(s)
- Rama Mahran
- 1Univ. of Michigan Medical Ctr., Ann Arbor, MI
| | - Pan Shu
- 2Univ. of Michigan, Ann Arbor, MI
| | | | | |
Collapse
|
16
|
Laliberte JC, Dame MK, Attili D, Islam B, Kim K, Zhang J, Katz EL, Newsome GM, Dedhia PH, Kruger A, Mann T, Goodman T, Buis J, Brenner DE, Varani J, Spence JR, Colacino JA, Stoerker J. Abstract LB-093: Simultaneous measurement of global methylation and copy number alterations in human colorectal cancer samples. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-lb-093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Epigenomic changes are commonly observed in cancer. We developed a next-generation sequencing (NGS) assay which can identify subtle changes in global methylation as well as copy number alterations (CNAs). The assay measures the methylation level of some repeat elements, covering over 25% of all CpG in the genome.
Genomic DNA extracted from 18 pairs of matched colorectal tumor to normal tissue was tested (four adenocarcinomas, including one associated with inflammatory bowel disease, and fourteen adenomas, including one adenoma from a Lynch syndrome patient, one familial adenomatous polyposis (FAP) and two sessile serrated adenomas (SSA)). We also assayed organoids established from these tissues at early (2 month) and late (more than 6 months) timepoints in culture. Briefly, bisulfite conversion and enrichment of the repeats was performed. The Illumina compatible products were sequenced on a HiSEQ 2500. Analysis was performed using Bismark (Krueger F., Babraham institute) and Nexus copy number (BioDiscovery) to determine the global methylation and the CNAs, respectively. Finally, somatic and germline variants were determined by targeted sequencing of 71 genes using the QIAseq colorectal cancer panel (QIAGEN).
Our data showed that all adenocarcinoma presented hypomethylation and CNAs as well as multiple somatic variants in APC, KRAS, TP53, SMAD4 and PIK3CA. Six out of the fourteen adenomas presented CNAs and nine showed hypomethylation. The most frequently observed copy number gain affected the chromosomes 8q and 13. Eight adenomas presenting somatic mutations in APC also exhibited distinct global hypomethylation. Previous publications have reported that mutations in APC precede global hypomethylation. Interestingly, one adenoma showed significant hypomethylation but no detectable CNAs or APC mutations. The two SSA samples showed the characteristic BRAF V600E mutations and the FAP sample presented germline mutation in APC. The FAP and the SSA samples did not show hypomethylation or CNAs. Most organoids presented CNAs and somatic mutations similar to their matched tissue even after 2 years in culture. However, few organoids developed new CNAs and somatic variants. Monitoring the changes in organoid may provide important information on tumor progression.
This assay measured CNAs and methylation in colorectal cancer samples, findings which may assist in determining the status of the disease and provide guidance to the appropriate action. Our NGS assay interrogates a significant portion of the genome leading to a more accurate and sensitive evaluation of the state of these cancer cells.
Note: This abstract was not presented at the meeting.
Citation Format: Julie C. Laliberte, Michael K. Dame, Durga Attili, Bodrul Islam, Kevin Kim, Jessica Zhang, Erica L. Katz, Gina M. Newsome, Priya H. Dedhia, Adele Kruger, Tobias Mann, Tom Goodman, Jeffrey Buis, Dean E. Brenner, James Varani, Jason R. Spence, Justin A. Colacino, Jay Stoerker. Simultaneous measurement of global methylation and copy number alterations in human colorectal cancer samples [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr LB-093. doi:10.1158/1538-7445.AM2017-LB-093
Collapse
Affiliation(s)
| | - Michael K. Dame
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Durga Attili
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Bodrul Islam
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Kevin Kim
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Jessica Zhang
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Erica L. Katz
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Gina M. Newsome
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Priya H. Dedhia
- 3Department of Surgery, University of Michigan, Ann Arbor, MI
| | | | | | | | | | - Dean E. Brenner
- 4Department of Pharmacology, Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI
| | - James Varani
- 2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Jason R. Spence
- 5Department of Internal Medicine, Division of Gastroenterology, Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI
| | - Justin A. Colacino
- 6Department of Environmental Health Sciences, Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI
| | | |
Collapse
|
17
|
Djuric Z, Aslam MN, Simon BR, Sen A, Jiang Y, Ren J, Chan R, Soni T, Rajendiran TM, Smith WL, Brenner DE. Fatty acid and lipidomic data in normal and tumor colon tissues of rats fed diets with and without fish oil. Data Brief 2017; 13:661-666. [PMID: 28725670 PMCID: PMC5503825 DOI: 10.1016/j.dib.2017.06.032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2017] [Revised: 05/30/2017] [Accepted: 06/19/2017] [Indexed: 12/11/2022] Open
Abstract
Data is provided to show the detailed fatty acid and lipidomic composition of normal and tumor rat colon tissues. Rats were fed either a Western fat diet or a fish oil diet, and half the rats from each diet group were treated with chemical carcinogens that induce colon cancer (azoxymethane and dextran sodium sulfate). The data show total fatty acid profiles of sera and of all the colon tissues, namely normal tissue from control rats and both normal and tumor tissues from carcinogen-treated rats, as obtained by gas chromatography with mass spectral detection. Data from lipidomic analyses of a representative subset of the colon tissue samples is also shown in heat maps generated from hierarchical cluster analysis. These data display the utility lipidomic analyses to enhance the interpretation of dietary feeding studies aimed at cancer prevention and support the findings published in the companion paper (Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors, Djuric et al., 2017 [1]).
Collapse
Affiliation(s)
- Zora Djuric
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, United States
- Corresponding author.
| | | | - Becky R. Simon
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, United States
| | - Ananda Sen
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, United States
- Departments of Statistics, University of Michigan, Ann Arbor, MI 48109, United States
| | - Yan Jiang
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, United States
| | - Jianwei Ren
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, United States
| | - Rena Chan
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, United States
| | - Tanu Soni
- Michigan Metabolomics Resource Center, University of Michigan, Ann Arbor, MI 48109, United States
| | | | - William L. Smith
- Department of Biochemistry, University of Michigan, Ann Arbor, MI 48109, United States
| | - Dean E. Brenner
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, United States
- Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, United States
| |
Collapse
|
18
|
Poneros JM, Faye AS, Barr Fritcher EG, Sen A, Anandasabapathy S, Bresalier RS, Marcon N, Turgeon DK, Appelman H, Normolle D, Morrison LE, Brenner DE, Halling KC. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus. Dig Dis Sci 2017; 62:1216-1222. [PMID: 28265829 PMCID: PMC6052443 DOI: 10.1007/s10620-017-4517-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2016] [Accepted: 02/26/2017] [Indexed: 12/20/2022]
Abstract
BACKGROUND AND AIMS Preliminary single-institution data suggest that fluorescence in situ hybridization (FISH) may be useful for detecting high-grade dysplasia (HGD) and esophageal adenocarcinoma (EA) in patients with Barrett's esophagus (BE). This multicenter study aims to validate the measurement of polysomy (gain of at least two loci) by FISH as a way to discriminate degrees of dysplasia in BE specimens. METHODS Tissue specimens were collected from four different hospitals and read by both the local pathology department ("Site diagnosis") and a single central pathologist ("Review diagnosis") at a separate institution. The specimens then underwent FISH analysis using probes 8q24 (MYC), 9p21 (CDKN2A), 17q12 (ERBB2), and 20q13 (ZNF217) for comparison. A total of 46 non-BE, 42 non-dysplastic specialized intestinal metaplasia (SIM), 23 indefinite-grade dysplasia (IGD), 10 low-grade dysplasia (LGD), 29 HGD, and 42 EA specimens were analyzed. RESULTS We found that polysomy, as detected by FISH, was the predominant chromosomal abnormality present as dysplasia increased. Polysomy was also the best predictor for the presence of dysplasia or EA when comparing its area under the curve to that of other FISH abnormalities. We observed that if at least 10% of cells had polysomy within a specimen, the FISH probe was able to differentiate between EA/HGD and the remaining pathologies with a sensitivity of 80% and a specificity of 88%. CONCLUSIONS This study demonstrates that using FISH to determine the percentage of cells with polysomy can accurately and objectively aid in the diagnosis of HGD/EA in BE specimens.
Collapse
Affiliation(s)
- John M. Poneros
- Department of Gastroenterology, Columbia University, Medical Center, 161 Fort Washington Avenue, Suite 862,, New York, NY 10032, USA
| | - Adam S. Faye
- Department of Internal Medicine, Columbia University, Medical Center, 177 Fort Washington Avenue, Milstein 6C-, 12, New York, NY 10032, USA
| | - Emily G. Barr Fritcher
- Department of Laboratory Medicine and Pathology, Mayo, Clinic, 200 First SW, Rochester, MN 55905, USA
| | - Ananda Sen
- Department of Biostatistics, University of Michigan Medical, Center, Ann Arbor, MI, USA,Department of Family Medicine, University of Michigan, Medical School, 1018 Fuller St., Ann Arbor, MI 48104, USA
| | - Sharmila Anandasabapathy
- Department of Gastroenterology, Baylor College of, Medicine, Baylor St. Luke’s Medical Center Clinic, 7200, Cambridge Street Suite 10C, Houston, TX 77030, USA
| | - Robert S. Bresalier
- Department of Gastroenterology, University of Texas M.D., Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1466,, Houston, TX 77030, USA
| | - Norman Marcon
- Department of Gastroenterology, University of Toronto,, Toronto, ON, Canada,St. Michael’s Hospital, University of Toronto, 30 Bond, Street, 16-062 Cardinal Carter South Wing, Toronto,, ON M5B 1W8, Canada
| | - D. Kim Turgeon
- Department of Internal Medicine, University of Michigan, Medical Center, Ann Arbor, MI, USA,Department of Gastroenterology, University of Michigan, Health System, Taubman Center Floor 3, Reception D,, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA
| | - Henry Appelman
- Department of Pathology, University of Michigan Medical, Center, 1301 Catherine St., Ann Arbor, MI 48109, USA
| | - Daniel Normolle
- Department of Biostatistics, University of Pittsburgh Cancer, Institute, 201 North Craig Street, Sterling Plaza Suite 325,, Pittsburgh, PA 15213, USA
| | | | - Dean E. Brenner
- Department of Internal Medicine, University of Michigan, Medical Center, Ann Arbor, MI, USA,Department of Pharmacology, University of Michigan, Medical Center, 1500 E Medical Center Dr #2150,, Ann Arbor, MI 48109, USA
| | - Kevin C. Halling
- Department of Laboratory Medicine and Pathology, Mayo, Clinic, 200 First SW, Rochester, MN 55905, USA
| |
Collapse
|
19
|
Djuric Z, Aslam MN, Simon BR, Sen A, Jiang Y, Ren J, Chan R, Soni T, Rajendiran TM, Smith WL, Brenner DE. Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors. J Nutr Biochem 2017; 46:90-99. [PMID: 28486173 DOI: 10.1016/j.jnutbio.2017.04.013] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2016] [Revised: 04/14/2017] [Accepted: 04/17/2017] [Indexed: 01/07/2023]
Abstract
Dietary fish oils have potential for prevention of colon cancer, and yet the mechanisms of action in normal and tumor colon tissues are not well defined. Here we evaluated the impact of the colonic fatty acid milieu on the formation of prostaglandins and other eicosanoids. Distal tumors in rats were chemically induced to model inflammatory colonic carcinogenesis. After 21 weeks of feeding with either a fish oil diet containing an eicosapentaenoic acid/ω-6 fatty acid ratio of 0.4 or a Western fat diet, the relationships between colon fatty acids and prostaglandin E2 (PGE2) concentrations were evaluated. PGE2 is a key proinflammatory mediator in the colon tightly linked with the initiation and progression of colon cancer. The fish oil vs. the Western fat diet resulted in reduced total fatty acid concentrations in serum but not in colon. In the colon, the effects of the fish oil on fatty acids differed in normal and tumor tissue. There were distinct lipodomic patterns consistent with a lipogenic phenotype in tumors. In tumor tissue, the eicosapentaenoic acid/arachidonic acid ratio, cyclooxygenase-2 expression and the mole percent of saturated fatty acids were significant predictors of inter-animal variability in colon PGE2 after accounting for diet. In normal tissues from either control rats or carcinogen-treated rats, only diet was a significant predictor of colon PGE2. These results show that the fatty acid milieu can modulate the efficacy of dietary fish oils for colon cancer prevention, and this could extend to other preventive agents that function by reducing inflammatory stress.
Collapse
Affiliation(s)
- Zora Djuric
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
| | | | - Becky R Simon
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
| | - Ananda Sen
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, USA; Department of Statistics, University of Michigan, Ann Arbor, MI 48109, USA
| | - Yan Jiang
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
| | - Jianwei Ren
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, USA
| | - Rena Chan
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, USA
| | - Tanu Soni
- Department of Michigan Metabolomics Resource Center, University of Michigan, Ann Arbor, MI 48109, USA
| | - T M Rajendiran
- Department of Michigan Metabolomics Resource Center, University of Michigan, Ann Arbor, MI 48109, USA
| | - William L Smith
- Department of Biochemistry, University of Michigan, Ann Arbor, MI 48109, USA
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA
| |
Collapse
|
20
|
Mahran RI, Hagras MM, Sun D, Brenner DE. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy. AAPS J 2016; 19:54-81. [DOI: 10.1208/s12248-016-0003-2] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Accepted: 10/04/2016] [Indexed: 01/28/2023]
|
21
|
Sidahmed E, Sen A, Ren J, Patel A, Turgeon DK, Ruffin MT, Brenner DE, Djuric Z. Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon Tissue. Nutr Cancer 2016; 68:1192-201. [PMID: 27548026 DOI: 10.1080/01635581.2016.1213866] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Prostaglandin E2 (PGE2) in the colon is a pro-inflammatory mediator that is associated with increased risk of colon cancer. In this study, expression of genes in the PGE2 pathway were quantified in colon biopsies from a trial of a Mediterranean versus a Healthy Eating diet in 113 individuals at high risk for colon cancer. Colon biopsies were obtained before and after 6 months of intervention. Quantitative, real-time PCR was used to measure mRNA expression of prostaglandin H synthases (PTGS1 and 2), prostaglandin E synthases (PTGES1 and 3), prostaglandin dehydrogenase (HPGD), and PGE2 receptors (PTGER2, PTGER4). The most highly expressed genes were HPGD and PTGS1. In multivariate linear regression models of baseline data, both colon saturated fatty acid concentrations and PTGS1 expression were significant, positive predictors of colon PGE2 concentrations after controlling for nonsteroidal anti-inflammatory drug use, gender, age, and smoking status. The effects of dietary intervention on gene expression were minimal with small increases in expression noted for PTGES3 in both arms and in PTGER4 in the Mediterranean arm. These results indicate that short-term dietary change had little effect on enzymes in the prostaglandin pathway in the colon and other factors, such as differences in fatty acid metabolism, might be more influential.
Collapse
Affiliation(s)
- ElKhansa Sidahmed
- a Department of Family Medicine , University of Michigan , Ann Arbor , MI , USA.,b Department of Environmental Health Sciences , University of Michigan , Ann Arbor , MI , USA.,c Department of Nutrition , Harvard T.H. Chan School of Public Health , Boston , MA , USA
| | - Ananda Sen
- a Department of Family Medicine , University of Michigan , Ann Arbor , MI , USA.,d Department of Biostatistics , University of Michigan , Ann Arbor , MI , USA
| | - Jianwei Ren
- a Department of Family Medicine , University of Michigan , Ann Arbor , MI , USA
| | - Arsh Patel
- a Department of Family Medicine , University of Michigan , Ann Arbor , MI , USA
| | - D Kim Turgeon
- e Department of Internal Medicine , University of Michigan , Ann Arbor , MI , USA
| | - Mack T Ruffin
- a Department of Family Medicine , University of Michigan , Ann Arbor , MI , USA
| | - Dean E Brenner
- e Department of Internal Medicine , University of Michigan , Ann Arbor , MI , USA
| | - Zora Djuric
- a Department of Family Medicine , University of Michigan , Ann Arbor , MI , USA.,b Department of Environmental Health Sciences , University of Michigan , Ann Arbor , MI , USA
| |
Collapse
|
22
|
Esper RM, Hill E, Jiang Y, Aslam N, Simon B, Wicha M, Smith W, Brenner DE. Abstract 2608: Dietary polyunsaturated fatty acids modulate adipose inflammation and the adipokine secretome to influence mammary stem cell self-renewal. Cancer Res 2016. [DOI: 10.1158/1538-7445.am2016-2608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Obesity strongly increases risk for multiple malignancies. One potential contributor may be the chronic low-grade inflammation that is likely driven by dysfunctional adipose characterized by aberrant adipokine production and macrophage activation/polarization. In adipose tissue, free fatty acids and their lipid mediators serve as important regulators of adipokine gene transcription. The adipocyte fatty acid composition is influenced by dietary availability. Here we present data demonstrating that dietary fish oil supplementation in obese rats (achieving a 2.5:1 ω6:ω3 PUFA ratio, comparable to a Mediterranean diet) attenuates adipose inflammation characterized reduction in the M1/M2 macrophage polarization ratio compared to a typical Western diet with a 20:1 ω6:ω3 PUFA ratio. We developed a novel adipose explant culture system to directly assay the secretome, and demonstrate that quenching adipose inflammation in obese animals is associated with a favorably rebalanced adipokine milieu, most notably increased adiponectin concentration and decreased leptin secretion. We previously showed that these two adipokines differentially modulate mammary stem cell self-renewal; here, we studied the effect of adipose conditioned media from obese rats on mammary stem cells using the mammosphere formation assay. Adipokines from obese rats fed the high-ω6 diet increased mammary stem cell symmetric self-renewal by 86.7 ± 7.5% (± SEM), whereas adipose-derived factors from the obese animals fed a low-ω6 diet supplemented with fish oil reduced the number of secondary mammospheres by 30.3 ± 10.1% by promoting either apoptosis, quiescence, or symmetric division-differentiation of the primary stem cells. Using a neutralizing antibody and a soluble receptor, we demonstrate that leptin contributes only 19% of the adipose-derived effect on mammary stem cell self-renewal. Taken together, our data suggests that a simple dietary intervention to modify the dietary PUFA ratio is an effective method to quench adipose inflammation and rebalance the adipokine milieu, which may modulate the mammary stem cell pool. If normal stem cells can give rise to breast cancer as has been theorized, then dietary interventions to quench adipose inflammation and reduce the rate of symmetric stem cell self-renewal might protect against the increased incidence of breast cancer seen in obese post-menopausal women.
Citation Format: Raymond M. Esper, Evan Hill, Yan Jiang, Nadeem Aslam, Becky Simon, Max Wicha, William Smith, Dean E. Brenner. Dietary polyunsaturated fatty acids modulate adipose inflammation and the adipokine secretome to influence mammary stem cell self-renewal. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2608.
Collapse
Affiliation(s)
| | - Evan Hill
- 1University of Michigan, Ann Arbor, MI
| | | | | | | | - Max Wicha
- 1University of Michigan, Ann Arbor, MI
| | | | | |
Collapse
|
23
|
Yu M, O'Leary RM, Kaz AM, Morris SM, Carter KT, Chak A, Chandar A, Willis JE, Moinova HR, Markowitz SD, Brenner DE, Anandabapasathy S, Westerhoff M, Wong CJ, Shaheen NJ, Chen Y, Barnholtz-Sloan JS, Grady WM. Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 2015; 24:1890-7. [PMID: 26545406 DOI: 10.1158/1055-9965.epi-15-0370] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2015] [Accepted: 09/30/2015] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND Barrett's esophagus (BE) is a preneoplastic condition in which normal esophageal squamous epithelium (SQ) is replaced by specialized intestinal metaplasia. It is the presumed precursor for esophageal adenocarcinoma (EAC) as well as the strongest risk factor for this cancer. Unfortunately, many patients with BE go undiagnosed under the current BE screening guidelines. The development of noninvasive and accurate BE detection assays could potentially identify many of these undiagnosed BE patients. METHODS DNA methylation is a common epigenetic alteration in BE. Therefore, we conducted a genome-wide methylation screen to identify potential BE biomarkers. Samples from SQ (N = 12), stomach (N = 28), and BE (N = 29) were analyzed and methylation levels at over 485,000 CpG sites were compared. Pyrosequencing assays were used to validate the results and MethyLight assays were developed to detect the methylated alleles in endoscopic brushings. RESULTS We discovered two genes, B3GAT2 and ZNF793, that are aberrantly methylated in BE. Clinical validation studies confirmed B3GAT2 and ZNF793 methylation levels were significantly higher in BE samples (median = 32.5% and 33.1%, respectively) than in control tissues (median = 2.29% and 2.52%, respectively; P < 0.0001 for both genes). Furthermore, gene-specific MethyLight assays could accurately detect BE (P < 0.0001 for both) in endoscopic brushing samples. CONCLUSION B3GAT2 and ZNF793 are hypermethylated in BE, and the methylation status of these genes can be used to detect BE in tissue samples. IMPACT These findings support the development of methylated B3GAT2 and ZNF793 as biomarkers for noninvasive assays for the detection of BE.
Collapse
Affiliation(s)
- Ming Yu
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Rachele M O'Leary
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Andrew M Kaz
- Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington. Department of Medicine, University of Washington School of Medicine, Seattle, Washington
| | - Shelli M Morris
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Kelly T Carter
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Amitabh Chak
- Division of Gastroenterology, University Hospitals Case Medical Center, Cleveland, Ohio. Division of Oncology, University Hospitals Case Medical Center, Cleveland, Ohio
| | - Apoorva Chandar
- Division of Gastroenterology, University Hospitals Case Medical Center, Cleveland, Ohio. Division of Oncology, University Hospitals Case Medical Center, Cleveland, Ohio
| | - Joseph E Willis
- Department of Pathology, University Hospitals Case Medical Center, Cleveland, Ohio
| | - Helen R Moinova
- Department of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
| | - Sanford D Markowitz
- Department of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio. Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, Ohio
| | - Dean E Brenner
- University of Michigan Medical Center, Ann Arbor, Michigan
| | | | - Maria Westerhoff
- Department of Anatomic Pathology, University of Washington School of Medicine, Seattle, Washington
| | - Chao-Jen Wong
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Nicholas J Shaheen
- Division of Gastroenterology & Hepatology, University of North Carolina Hospitals, Chapel Hill, North Carolina
| | - Yanwen Chen
- Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, Ohio
| | - Jill S Barnholtz-Sloan
- Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, Ohio
| | - William M Grady
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
| |
Collapse
|
24
|
Esper RM, Dame M, McClintock S, Holt PR, Dannenberg AJ, Wicha MS, Brenner DE. Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells. Cancer Prev Res (Phila) 2015; 8:1174-83. [PMID: 26487401 DOI: 10.1158/1940-6207.capr-14-0334] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2014] [Accepted: 10/09/2015] [Indexed: 12/23/2022]
Abstract
Multiple mechanisms are likely to account for the link between obesity and increased risk of postmenopausal breast cancer. Two adipokines, leptin and adiponectin, are of particular interest due to their opposing biologic functions and associations with breast cancer risk. In the current study, we investigated the effects of leptin and adiponectin on normal breast epithelial stem cells. Levels of leptin in human adipose explant-derived conditioned media positively correlated with the size of the normal breast stem cell pool. In contrast, an inverse relationship was found for adiponectin. Moreover, a strong linear relationship was observed between the leptin/adiponectin ratio in adipose conditioned media and breast stem cell self-renewal. Consistent with these findings, exogenous leptin stimulated whereas adiponectin suppressed breast stem cell self-renewal. In addition to local in-breast effects, circulating factors, including leptin and adiponectin, may contribute to the link between obesity and breast cancer. Increased levels of leptin and reduced amounts of adiponectin were found in serum from obese compared with age-matched lean postmenopausal women. Interestingly, serum from obese women increased stem cell self-renewal by 30% compared with only 7% for lean control serum. Taken together, these data suggest a plausible explanation for the obesity-driven increase in postmenopausal breast cancer risk. Leptin and adiponectin may function as both endocrine and paracrine/juxtacrine factors to modulate the size of the normal stem cell pool. Interventions that disrupt this axis and thereby normalize breast stem cell self-renewal could reduce the risk of breast cancer.
Collapse
Affiliation(s)
- Raymond M Esper
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
| | - Michael Dame
- Department of Internal Medicine Pathology, University of Michigan Medical School, Ann Arbor, Michigan
| | - Shannon McClintock
- Department of Internal Medicine Pathology, University of Michigan Medical School, Ann Arbor, Michigan
| | | | | | - Max S Wicha
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan. Department of Internal Medicine Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan. VA Medical Center, Ann Arbor, Michigan
| |
Collapse
|
25
|
Zhang H, Ramakrishnan SK, Triner D, Centofanti B, Maitra D, Győrffy B, Sebolt-Leopold JS, Dame MK, Varani J, Brenner DE, Fearon ER, Omary MB, Shah YM. Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Sci Signal 2015; 8:ra98. [PMID: 26443705 DOI: 10.1126/scisignal.aac5418] [Citation(s) in RCA: 140] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Yes-associated protein 1 (YAP1) is a transcriptional coactivator in the Hippo signaling pathway. Increased YAP1 activity promotes the growth of tumors, including that of colorectal cancer (CRC). Verteporfin, a drug that enhances phototherapy to treat neovascular macular degeneration, is an inhibitor of YAP1. We found that verteporfin inhibited tumor growth independently of its effects on YAP1 or the related protein TAZ in genetically or chemically induced mouse models of CRC, in patient-derived xenografts, and in enteroid models of CRC. Instead, verteporfin exhibited in vivo selectivity for killing tumor cells in part by impairing the global clearance of high-molecular weight oligomerized proteins, particularly p62 (a sequestrome involved in autophagy) and STAT3 (signal transducer and activator of transcription 3; a transcription factor). Verteporfin inhibited cytokine-induced STAT3 activity and cell proliferation and reduced the viability of cultured CRC cells. Although verteporfin accumulated to a greater extent in normal cells than in tumor cells in vivo, experiments with cultured cells indicated that the normal cells efficiently cleared verteporfin-induced protein oligomers through autophagic and proteasomal pathways. Culturing CRC cells under hypoxic or nutrient-deprived conditions (modeling a typical CRC microenvironment) impaired the clearance of protein oligomers and resulted in cell death, whereas culturing cells under normoxic or glucose-replete conditions protected cell viability and proliferation in the presence of verteporfin. Furthermore, verteporfin suppressed the proliferation of other cancer cell lines even in the absence of YAP1, suggesting that verteporfin may be effective against multiple types of solid cancers.
Collapse
Affiliation(s)
- Huabing Zhang
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Sadeesh K Ramakrishnan
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Daniel Triner
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Brook Centofanti
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Dhiman Maitra
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Balázs Győrffy
- MTA TTK Lendület Cancer Biomarker Research Group, MTA-SE Pediatrics and Nephrology Research Group, Semmelweis University 2nd Department of Pediatrics, Budapest H-1117, Hungary
| | | | - Michael K Dame
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - James Varani
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Dean E Brenner
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - Eric R Fearon
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA
| | - M Bishr Omary
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Department of Veterans Affairs Ann Arbor Health Care System, Ann Arbor, MI 48105, USA
| | - Yatrik M Shah
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
| |
Collapse
|
26
|
Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, Kucherlapati R, Boutin AT, Wang YA, DePinho RA, Feng Z, Lampe PD, Hanash SM. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Cancer Prev Res (Phila) 2015; 8:1112-9. [PMID: 26342024 DOI: 10.1158/1940-6207.capr-15-0077] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2015] [Accepted: 08/20/2015] [Indexed: 12/19/2022]
Abstract
Blood-based biomarkers for early detection of colorectal cancer could complement current approaches to colorectal cancer screening. We previously identified the APC-binding protein MAPRE1 as a potential colorectal cancer biomarker. Here, we undertook a case-control validation study to determine the performance of MAPRE1 in detecting early colorectal cancer and colon adenoma and to assess the potential relevance of additional biomarker candidates. We analyzed plasma samples from 60 patients with adenomas, 30 with early colorectal cancer, 30 with advanced colorectal cancer, and 60 healthy controls. MAPRE1 and a set of 21 proteins with potential biomarker utility were assayed using high-density antibody arrays, and carcinoembryonic antigen (CEA) was assayed using ELISA. The biologic significance of the candidate biomarkers was also assessed in colorectal cancer mouse models. Plasma MAPRE1 levels were significantly elevated in both patients with adenomas and patients with colorectal cancer compared with controls (P < 0.0001). MAPRE1 and CEA together yielded an area under the curve of 0.793 and a sensitivity of 0.400 at 95% specificity for differentiating early colorectal cancer from controls. Three other biomarkers (AK1, CLIC1, and SOD1) were significantly increased in both adenoma and early colorectal cancer patient plasma samples and in plasma from colorectal cancer mouse models at preclinical stages compared with controls. The combination of MAPRE1, CEA, and AK1 yielded sensitivities of 0.483 and 0.533 at 90% specificity and sensitivities of 0.350 and 0.467 at 95% specificity for differentiating adenoma and early colorectal cancer, respectively, from healthy controls. These findings suggest that MAPRE1 can contribute to the detection of early-stage colorectal cancer and adenomas together with other biomarkers.
Collapse
Affiliation(s)
- Ayumu Taguchi
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
| | - Jung-Hyun Rho
- Translational Research Program, Human Biology and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Qingxiang Yan
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Yuzheng Zhang
- Translational Research Program, Human Biology and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Yang Zhao
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Hanwen Xu
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Satyendra Chandra Tripathi
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Hong Wang
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan. VA Medical Center, Ann Arbor, Michigan
| | | | - Raju Kucherlapati
- Department of Genetics, Harvard Medical School, Boston, Massachusetts
| | - Adam T Boutin
- Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Y Alan Wang
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Ronald A DePinho
- Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Ziding Feng
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Paul D Lampe
- Translational Research Program, Human Biology and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Samir M Hanash
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas
| |
Collapse
|
27
|
Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, Brenner DE. Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer. Mol Carcinog 2015; 54:908-15. [PMID: 24760534 PMCID: PMC4208969 DOI: 10.1002/mc.22163] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Revised: 03/21/2014] [Accepted: 03/27/2014] [Indexed: 12/24/2022]
Abstract
Colorectal cancer (CRC) remains a significant cause of mortality. Inhibitors of cyclooxygenase (COX) and thus prostaglandin E2, are promising CRC preventives, but have significant toxicities. Ginger has been shown to inhibit COX, to decrease the incidence and multiplicity of adenomas, and decrease PGE2 concentrations in subjects at normal risk for CRC. This study was conducted to determine the effects of 2.0 g/d of ginger given orally on the levels of PGE2, leukotriene B4 (LTB4), 13-hydroxy-octadecadienoic acids, and 5-, 12-, & 15-hydroxyeicosatetraenoic acid, in the colonic mucosa of subjects at increased risk for CRC. We randomized 20 subjects to 2.0 g/d ginger or placebo for 28 d. At baseline and Day 28, a flexible sigmoidoscopy was used to obtain colon biopsies. A liquid chromatography mass spectrometry method was used to determine eicosanoid levels in the biopsies, and levels were expressed per amount of protein or free arachidonic acid (AA). There was a significant decrease in AA between baseline and Day 28 (P = 0.05) and significant increase in LTB4 (P = 0.04) when normalized to protein, in subjects treated with ginger versus placebo. No other changes in eicosanoids were observed. There was no difference between the groups in total adverse events (AE; P = 0.06). Ginger lacks the ability to decrease eicosanoid levels in people at increased risk for CRC. Ginger did appear to be both tolerable and safe; and could have chemopreventive effects through other mechanisms. Further investigation should focus on other markers of CRC risk in those at increased CRC risk.
Collapse
Affiliation(s)
- Suzanna M Zick
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
- University of Micihgan School of Public Health Department of Enviromental Health Sciences, Ann Arbor, Michigan
| | - D Kim Turgeon
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Jianwei Ren
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Mack T Ruffin
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Benjamin D Wright
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Ananda Sen
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Zora Djuric
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
- University of Micihgan School of Public Health Department of Enviromental Health Sciences, Ann Arbor, Michigan
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan
- VA Medical Center, Ann Arbor, Michigan
| |
Collapse
|
28
|
Dame MK, McClintock SD, Attili D, Simon B, Copley K, Finkbeiner S, Altheim C, Spence J, Appelman H, Turgeon DK, Samuelson LC, Brenner DE, Varani J. Abstract 322: Establishment and genomic characterization of enteroid cultures from human colonic adenomas and adenocarcinomas. Cancer Res 2015. [DOI: 10.1158/1538-7445.am2015-322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction Characterized enteroid cultures of human colon cancer can more precisely model the diversity of colonic neoplasia for the study of cancer initiation, progression and potentially prevention. Using tissue from colon resections and endoscopic biopsies, we have successfully isolated and cultured 14 colorectal adenomas and 2 adenocarcinomas to date. We have maintained these enteroid cultures for up to 2 years and established a working cryorepository. Specific epithelial cell lineage markers and the stem cell marker Lgr5 can be detected throughout the culture period.
Methods Enteroid cultures have been initiated and maintained in a serum-free medium containing EGF and pituitary extract. However, approximately half of all neoplasms do not establish in this reduced medium. In contrast, most neoplasms develop and expand in an enriched culture medium containing serum, Wnt, R-spondin, Noggin, and EGF. We have also created a mouse xenograft from an adenoma expanded in the reduced media; this graft was then successfully reintroduced into culture. Using whole exome sequencing, we are investigating how the genetic background of individual patients contributes to 1) variability in the establishment and expansion of enteroid cultures 2) tumor heterogeneity in neoplasms and xenografts, and 3) the stability of genomic signatures in enteroids over time in culture.
Results Twenty-two damaging somatic variants identified in a single colon tumor were preserved in enteroid culture after 2 months in reduced medium. Variants included a frameshift mutation in APC and missense mutations in KRAS and TP53. The allele frequency of most variants increased in enteroid culture, suggesting that cells lacking these mutations failed to propagate (including stromal/immune cells), or cells carrying these mutations expanded at a faster rate. Ten mutations not present in the original tumor were acquired over time in enteroid culture. These mutations included a missense variant of TRPS1, a putative prognosticator of colon cancer. The mutations acquired in enteroid culture may reflect genetic instability in the source neoplastic tissue, or the emergence of subpopulations that were below level of detection in the source tissue. Three mutations were present in the tumor and lost in enteroid culture; this presumably reflects the loss of a subset of cells expressing these variants.
Conclusion Changes in allele frequencies suggest that neoplasms are heterogeneous, with shifting cell populations that are differentially affected by culture conditions. This heterogeneity can be further interrogated by comparing allele frequencies in the original tumor with those in enteroids established in reduced or enriched media. This platform can provide further understanding of genetic determinants that underlie the risk for colorectal cancer, as well as strategic insights into the enteroid model as a sophisticated system for the study of tumor biology.
Citation Format: Michael K. Dame, Shannon D. McClintock, Durga Attili, Becky Simon, Kelly Copley, Stacy Finkbeiner, Christopher Altheim, Jason Spence, Henry Appelman, D Kim Turgeon, Linda C. Samuelson, Dean E. Brenner, James Varani. Establishment and genomic characterization of enteroid cultures from human colonic adenomas and adenocarcinomas. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 322. doi:10.1158/1538-7445.AM2015-322
Collapse
Affiliation(s)
- Michael K. Dame
- 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | | | - Durga Attili
- 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Becky Simon
- 2Internal Medicine, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
| | - Kelly Copley
- 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - Stacy Finkbeiner
- 3Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI
| | - Christopher Altheim
- 3Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI
| | - Jason Spence
- 3Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI
| | - Henry Appelman
- 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| | - D Kim Turgeon
- 3Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI
| | - Linda C. Samuelson
- 3Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI
| | - Dean E. Brenner
- 2Internal Medicine, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
| | - James Varani
- 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
| |
Collapse
|
29
|
Umoh FI, Kato I, Ren J, Wachowiak PL, Ruffin MT, Turgeon DK, Sen A, Brenner DE, Djuric Z. Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study. Eur J Nutr 2015; 55:793-798. [PMID: 25903259 DOI: 10.1007/s00394-015-0900-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2015] [Accepted: 04/07/2015] [Indexed: 12/17/2022]
Abstract
PURPOSE Systemic exposures to intestinal bacteria may play a role in the etiology of the chronic, low-grade inflammation that is associated with western diets. Production of lipopolysaccharide-binding protein (LBP) is one biomarker of increased exposures to intestinal bacteria. This study evaluated whether changes in diet quality could affect serum LBP. METHODS This was a randomized, controlled trial of Mediterranean and Healthy Eating diets over 6 months in 120 healthy subjects at increased risk of colon cancer. Blood samples obtained before and after intervention were analyzed for LBP, branched-chain fatty acids characteristic of intestinal bacteria, micronutrients and cytokines. Data were analyzed for changes in LBP over time and for predictors of LBP. RESULTS Serum concentrations of branched-chain bacterial fatty acids declined significantly in both diet groups. However, there was no significant change in mean serum LBP concentrations with either diet intervention. In serum, LBP was positively associated with CRP and negatively associated with carotenoids both before and after intervention. After intervention, LBP was predicted positively by both CRP and bacterial fatty acid concentrations in serum, and negatively by serum carotenoids and the ω3/ω6 fatty acid ratio. This model accounted for 30 % of the inter-individual variation in serum LBP after intervention. CONCLUSIONS These results indicate that dietary intervention over 6 months was insufficient to alter serum LBP. The relationships with inflammation-related markers, however, indicate that anti-inflammatory strategies other than changes in diet quality, such as weight loss or improved fitness, may have more potential for reducing systemic markers of LPS exposures in well-nourished populations.
Collapse
Affiliation(s)
- Faith I Umoh
- Department of Family Medicine, University of Michigan, 1500 E. Medical Center Drive, Room 2150 Cancer Center, Ann Arbor, MI, 48109-5930, USA
| | - Ikuko Kato
- Department of Pathology and Karmanos Cancer Institute, Wayne State University, Detroit, MI, 48201, USA
| | - Jianwei Ren
- Department of Family Medicine, University of Michigan, 1500 E. Medical Center Drive, Room 2150 Cancer Center, Ann Arbor, MI, 48109-5930, USA
| | - Phillip L Wachowiak
- Department of Family Medicine, University of Michigan, 1500 E. Medical Center Drive, Room 2150 Cancer Center, Ann Arbor, MI, 48109-5930, USA
| | - Mack T Ruffin
- Department of Family Medicine, University of Michigan, 1500 E. Medical Center Drive, Room 2150 Cancer Center, Ann Arbor, MI, 48109-5930, USA
| | - D Kim Turgeon
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109-5930, USA
| | - Ananda Sen
- Department of Family Medicine, University of Michigan, 1500 E. Medical Center Drive, Room 2150 Cancer Center, Ann Arbor, MI, 48109-5930, USA.,Department of Statistics, University of Michigan, Ann Arbor, MI, 48109-5930, USA
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109-5930, USA.,Department of Pharmacology, University of Michigan, Ann Arbor, MI, 48109-5930, USA
| | - Zora Djuric
- Department of Family Medicine, University of Michigan, 1500 E. Medical Center Drive, Room 2150 Cancer Center, Ann Arbor, MI, 48109-5930, USA.
| |
Collapse
|
30
|
Djuric Z, Turgeon DK, Ren J, Neilson A, Plegue M, Waters IG, Chan A, Askew LM, Ruffin MT, Sen A, Brenner DE. Effects of a Mediterranean Diet Intervention on Anti- and Pro-Inflammatory Eicosanoids, Epithelial Proliferation, and Nuclear Morphology in Biopsies of Normal Colon Tissue. Nutr Cancer 2015; 67:721-9. [PMID: 25869112 DOI: 10.1080/01635581.2015.1029637] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
This randomized trial evaluated the effects of intervention with either a Healthy Eating or a Mediterranean diet on colon biomarkers in 120 healthy individuals at increased colon cancer risk. The hypothesis was that eicosanoids and markers of proliferation would be favorably affected by the Mediterranean diet. Colon epithelial biopsy tissues and blood samples were obtained at baseline and after 6 mo of intervention. Colonic eicosanoid concentrations were evaluated by HPLC-MS-MS, and measures of epithelial proliferation and nuclear morphology were evaluated by image analysis of biopsy sections. There was little change in proinflammatory eicosanoids and in plasma cytokine concentrations with either dietary intervention. There was, however, a 50% increase in colonic prostaglandin E3 (PGE3), which is formed from eicosapentanoic acid, in the Mediterranean arm. Unlike PGE2, PGE3, was not significantly affected by regular use of non-steroidal anti-inflammatory drugs at baseline, and normal weight subjects had significantly higher colon PGE3 than overweight or obese subjects. Increased proliferation in the colon at baseline, by Ki67 labeling, was associated with morphological features that defined smaller nuclei in the epithelial cells, lower colon leukotriene concentrations and higher plasma cytokine concentrations. Dietary intervention had little effect on measures of epithelial proliferation or of nuclear morphology. The increase in PGE3 with a Mediterranean diet indicates that in normal colon, diet might affect protective pathways to a greater extent than proinflammatory and proliferative pathways. Hence, biomarkers from cancer models might not be relevant in a true prevention setting.
Collapse
Affiliation(s)
- Zora Djuric
- a Department of Family Medicine and Department of Environmental Health Sciences , University of Michigan , Ann Arbor , Michigan , USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Bresalier RS, Kopetz S, Brenner DE. Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test? Dig Dis Sci 2015; 60:664-71. [PMID: 25680874 DOI: 10.1007/s10620-015-3575-2] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Accepted: 01/31/2015] [Indexed: 02/06/2023]
Abstract
Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10% of the total cancer burden with an individual lifetime risk of ~6% in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.
Collapse
Affiliation(s)
- Robert S Bresalier
- Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1466, Houston, TX, 77030, USA,
| | | | | |
Collapse
|
32
|
Li Y, Sen A, Ren J, Askew LM, Sidahmed E, Brenner DE, Ruffin MT, Turgeon DK, Djuric Z. Effects of vitamin E from supplements and diet on colonic α- and γ-tocopherol concentrations in persons at increased colon cancer risk. Nutr Cancer 2014; 67:73-81. [PMID: 25372556 DOI: 10.1080/01635581.2015.965333] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
The available evidence indicates that γ-tocopherol has more potential for colon cancer prevention than α-tocopherol, but little is known about the effects of foods and supplements on tocopherol levels in human colon. This study randomized 120 subjects at increased colon cancer risk to either a Mediterranean or a Healthy Eating diet for 6 mo. Supplement use was reported by 39% of the subjects, and vitamin E intake from supplements was twofold higher than that from foods. Serum α-tocopherol at baseline was positively predicted by dietary intakes of synthetic vitamin E in foods and supplements but not by natural α-tocopherol from foods. For serum γ-tocopherol, dietary γ-tocopherol was not a predictor, but dietary α-tocopherol was a negative predictor. Unlike with serum, the data supported a role for metabolic factors, and not a direct effect of diet, in governing concentrations of both α- and γ-tocopherol in colon. The Mediterranean intervention increased intakes of natural α-tocopherol, which is high in nuts, and decreased intakes of γ-tocopherol, which is low in olive oil. These dietary changes had no significant effects on colon tocopherols. The impact of diet on colon tocopherols therefore appears to be limited.
Collapse
Affiliation(s)
- Yiting Li
- a Department of Family Medicine , University of Michigan , Ann Arbor , Michigan , USA
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Jiang Y, Djuric Z, Sen A, Ren J, Kuklev D, Waters I, Zhao L, Uhlson CL, Hong YH, Murphy RC, Normolle DP, Smith WL, Brenner DE. Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila) 2014; 7:1011-22. [PMID: 25139294 DOI: 10.1158/1940-6207.capr-14-0134] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Prostaglandin E2 (PGE2) has been linked to a higher risk of colorectal cancer. PGE2 in colon tissue can be reduced by increasing dietary eicosapentaenoic acid (EPA). The dose-dependent relationships between dietary EPA, serum EPA:arachidonate (AA) ratio, urinary PGE2 metabolites, and colonic eicosanoids were evaluated to develop biomarkers for prediction of colonic PGE2. Male rats were fed diets containing EPA:ω6 fatty acid ratios of 0, 0.1, 0.2, 0.4, or 0.6 for 5 weeks. Increasing the dietary EPA:ω6 fatty acid ratio increased EPA:AA ratios in serum and in the proximal, transverse, and distal colon (P < 0.001). The urinary PGE2 metabolite was reduced (P = 0.006). EPA-rich diets reduced colonic tissue PGE2 concentrations by 58% to 66% and increased PGE3 by 19- to 28-fold. Other AA-derived eicosanoids were reduced by 35% to 83%. The changes were not linear, with the largest changes in eicosanoids observed with the lower doses. A mathematical model predicts colonic tissue eicosanoids from the EPA:AA ratio in serum and the EPA dose. Every 10% increase in serum EPA:AA was associated with a 2% decrease in the (geometric) mean of PGE2 in the distal colon. These mathematical relationships can now be applied to individualized EPA dosing in clinical trials.
Collapse
Affiliation(s)
- Yan Jiang
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Zora Djuric
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Ananda Sen
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Jianwei Ren
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Dmitry Kuklev
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan
| | - Ian Waters
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan
| | - Lili Zhao
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan
| | - Charis L Uhlson
- Department of Pharmacology, University of Colorado Denver, Aurora, Colorado
| | - Yu H Hong
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan
| | - Robert C Murphy
- Department of Pharmacology, University of Colorado Denver, Aurora, Colorado
| | - Daniel P Normolle
- Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - William L Smith
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan
| | - Dean E Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan. Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan. VA Medical Center, Ann Arbor, Michigan.
| |
Collapse
|
34
|
Patel KR, Andreadi C, Britton RG, Horner-Glister E, Karmokar A, Sale S, Brown VA, Brenner DE, Singh R, Steward WP, Gescher AJ, Brown K. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med 2013; 5:205ra133. [PMID: 24089405 DOI: 10.1126/scitranslmed.3005870] [Citation(s) in RCA: 146] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
The phytochemical resveratrol has been shown to exert numerous health benefits in preclinical studies, but its rapid metabolism and resulting poor bioavailability may limit translation of these effects to humans. Resveratrol metabolites might contribute to in vivo activity through regeneration of the parent compound. We present quantitation of sulfate and glucuronide conjugates of resveratrol in human plasma and tissue after repeated ingestion of resveratrol by volunteers and cancer patients, respectively. Subsequent pharmacokinetic characterization of a mixture of resveratrol-3-O-sulfate and resveratrol-4'-O-sulfate in mice showed that these metabolites are absorbed orally but have low bioavailabilities of ~14 and 3%, respectively. Sulfate hydrolysis in vivo liberated free resveratrol, which accounted for ~2% of the total resveratrol species present in mouse plasma. Monosulfate metabolites were also converted to the parent in human colorectal cells. The extent of cellular uptake was dependent on specific membrane transporters and dictated antiproliferative activity. Sulfate metabolites induced autophagy and senescence in human cancer cells; these effects were abrogated by inclusion of a sulfatase inhibitor, which reduced intracellular resveratrol. Together, our findings suggest that resveratrol is delivered to target tissues in a stable sulfate-conjugated form and that the parent compound is gradually regenerated in selected cells and may give rise to the beneficial effects in vivo. At doses considered to be safe in humans, resveratrol generated via this route may be of greater importance than the unmetabolized form.
Collapse
Affiliation(s)
- Ketan R Patel
- Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Azrad M, Vollmer RT, Madden J, Dewhirst M, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner DE, Demark-Wahnefried W. Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer. J Med Food 2013; 16:357-60. [PMID: 23566060 DOI: 10.1089/jmf.2012.0159] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
Enterolactone and enterodiol, mammalian lignans derived from dietary sources such as flaxseed, sesame seeds, kale, broccoli, and apricots, may impede tumor proliferation by inhibiting activation of nuclear factor kappa B (NFκB) and vascular endothelial growth factor (VEGF). We examined the associations between urinary enterolactone and enterodiol with prostatic tumor expression of NFκB, VEGF, and Ki67 among 147 patients with prostate cancer who participated in a presurgical trial of flaxseed supplementation (30 g/day) for ~30 days. Urinary enterolignans and tissue biomarkers were determined by high-performance liquid chromatography and immunohistochemistry, respectively. After supplementation, we observed significant correlations between intakes of plant lignan and urinary concentrations of total enterolignans (ρ=0.677, P<.0001), enterolactone (ρ=0.676, P<.0001), and enterodiol (ρ=0.628, P<.0001). Importantly, we observed that total urinary enterolignans and enterolactone were significantly and inversely correlated with Ki67 in the tumor tissue (ρ=-0.217, P=.011, and ρ=-0.230, P=.007, respectively), and a near-significant inverse association was observed for enterodiol (ρ=-0.159, P=.064). An inverse association was observed between enterolactone and VEGF (ρ=-0.143, P=.141), although this did not reach statistical significance. We did not observe an association between enterolignans and NFκB. In conclusion, flaxseed-derived enterolignans may hinder cancer cell proliferation via VEGF-associated pathways.
Collapse
Affiliation(s)
- Maria Azrad
- Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Jiang Y, Turgeon DK, Wright BD, Sidahmed E, Ruffin MT, Brenner DE, Sen A, Zick SM. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer. Eur J Cancer Prev 2013; 22:455-60. [PMID: 23222413 PMCID: PMC3720765 DOI: 10.1097/cej.0b013e32835c829b] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Elevated tissue levels of prostaglandin E2, produced by cyclooxygenase (COX), are an early event in colorectal cancer (CRC). Data suggest the efficacy of nonsteroidal anti-inflammatory drugs, such as cancer preventives, in the inhibition of COX activity; however, side effects of nonsteroidal anti-inflammatory pose unacceptable limitations. Ginger has been reported to have anti-inflammatory activities with significant CRC preventive potential. We investigated whether consumption of 2.0 g ginger daily regulated the level of two key enzymes that control prostaglandin E2 production, COX-1 and NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). Thirty participants at normal and 20 participants at increased risk for CRC were randomized and given 2.0 g/day ginger or placebo for 28 days. Flexible sigmoidoscopy was used to obtain colon biopsies at baseline and the end of the study. Tissue levels of COX-1 and 15-PGDH were assessed using western blotting. After ginger consumption, participants at increased risk for CRC had a significantly reduced colonic COX-1 protein level (23.8±41%) compared with the placebo group (18.9±52%; P=0.03). Protein levels of 15-PGDH in the colon were unchanged. In participants who were at normal risk for CRC, neither protein levels of COX-1 nor 15-PGDH in the colon were altered by ginger consumption. Ginger significantly lowered COX-1 protein expression in participants at increased risk for CRC but not in those at normal risk for CRC. Ginger did not alter 15-PGDH protein expression in either increased or normal-risk participants. Further investigation, in larger studies with a longer ginger intervention, is needed to examine the ability of ginger to impact tissue levels of prostaglandin.
Collapse
Affiliation(s)
- Yan Jiang
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105
| | - D. Kim Turgeon
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105
| | - Benjamin D. Wright
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI 48104
| | - Elkhansa Sidahmed
- Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI 48105
| | - Mack T. Ruffin
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI 48104
| | - Dean E. Brenner
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI
- VA Medical Center, Ann Arbor, MI 48105
| | - Ananda Sen
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI 48104
| | - Suzanna M. Zick
- Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI 48104
| |
Collapse
|
37
|
Sen A, Ren J, Ruffin MT, Turgeon DK, Brenner DE, Sidahmed E, Rapai ME, Cornellier ML, Djuric Z. Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial. Cancer Prev Res (Phila) 2013; 6:558-65. [PMID: 23592741 DOI: 10.1158/1940-6207.capr-13-0019] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Little is known about the effect of preventive diets on colonic nutrient concentrations. This study randomized 120 persons at increased risk of colon cancer to a Mediterranean versus a Healthy Eating diet for six months. The former targeted increases in whole grains, fruits, vegetables, monounsaturated, and n3 fats. The Healthy Eating diet was based on Healthy People 2010 recommendations. At baseline, dietary fat and carotenoid intakes were poorly associated (Spearman ρ < 0.4) with serum and colon concentrations. Strong associations were observed between serum and colon measurements of β-cryptoxanthin (ρ = 0.58; P < 0.001), α-carotene (ρ = 0.48; P < 0.001), and β-carotene (ρ = 0.45; P < 0.001). After six months, the Healthy Eating intervention increased serum lutein, β-, and α-carotene significantly (P < 0.05). In the Mediterranean arm, the significant increases were in serum lutein, β-cryptoxanthin, β-carotene, monounsaturated, and n3 fats. A significant group-by-time interaction (P = 0.03) was obtained for monounsaturated fats. Colonic increases in carotenoids and n3 fats were significant only in Healthy Eating arm, whereas the group-by-time interaction was significant for β-carotene (P = 0.02) and α-carotene (P = 0.03). Changes in colon concentrations were not significantly associated with reported dietary changes. Changes in colon and serum concentrations were strongly associated for β-cryptoxanthin (ρ = 0.56; P < 0.001) and α-carotene (ρ = 0.40; P < 0.001). The associations between colonic and serum concentrations suggest the potential use of using serum concentration as a target in dietary interventions aimed at reducing colon cancer risk.
Collapse
Affiliation(s)
- Ananda Sen
- Department of Family Medicine, University of Michigan Medical Center, 1018 Fuller St., Ann Arbor, MI 48104, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Jiang Y, Djuric Z, Ren J, Dmitry KV, Curtis A, Bentz GS, Waters I, Sen A, Zhao L, Uhlson C, Murphy R, Smith WL, Brenner DE. Abstract 4863: Prostaglandin and associated eicosanoid dose response to omega-3 fatty acid (FA) diet in rat colon. Cancer Res 2013. [DOI: 10.1158/1538-7445.am2013-4863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Prostaglandin (PG) E2 has been linked to higher risk of colorectal carcinogenesis. Our previous in vitro data (Wada et al. J Biol Chem 2007;282;22254) demonstrated reduction of cellular eicosanoids by substituting the n-3 fatty acid EPA for the more common n-6 FA arachidonic acid (AA) as substrate for the cyclooxygenases (Cox). We tested the hypothesis that EPA substitution for n-6 FA in vivo will reduce procarcinogenic eicosanoids in rats.
Methods: F344 male rats were fed EPA: n-6 FA ratio diets of 0, 0.1, 0.2, 0.4, 0.6 for 5 weeks. Eicosanoids (PGs and lipoxins) in proximal, transverse and distal colonic tissue and urinary PG metabolites were assayed on LC-MS-MS. Fatty acids in serum and tissue were measured by GC-MS.
Results: Serum EPA:AA ratio (means(SD)) increased linearly from 0.02(0.004) at baseline (no EPA) to 0.98(0.32) EPA:n-6 ratio of 0.6. Colonic EPA:AA ratios increased from 0.03(0.01) to 0.41(0.15) in distal colon. Representative eicosanoid concentrations (μg/mg protein) in distal colon tissue with associated EPA:n-6 diets in the Table suggest rapid eicosanoid reduction at lower dietary EPA:n-6 ratios and then flattening of the dose response at higher ratios. The distal colon contained the lowest eicosanoid concentrations compared to transverse and proximal colon. Urinary PGE metabolite was reduced from 13.42(1.95) ng/mg creatinine (dietary EPA:n-6 FA=0) to 7.67(0.62) ng/mg creatinine (dietary EPA:n-6 FA=0.6).
Conclusion: Diet induced substitution of omega-3 for omega-6 substrates of Cox and lipoxygenases in F-344 rats causes a rapid, non-linear decline in colonic PGE2 and lipoxin products. PGE3 increases linearly with omega-3 FA dose. These data support the hypothesis that reduction in carcinogenesis stress induced by eicosanoids can be modulated by a dietary intervention in vivo.
Eicosanoids in rat colon EPA: n-6 ratio in diet PGE2 PGE3 5-HETE 12-HETE 0 264.43(77.54) 0.12 (0.14) 2.28 (1.74) 35.67 (26.95) 0.2 116.56 (50.53) 0.89 (0.81) 1.15 (0.99) 11.73 (7.65) 0.4 86.15 (27.28) 1.52 (0.96) 1.80 (2.02) 5.93 (4.01) 0.6 90.89 (20.90) 2.17 (1.36) 1.52 (0.78) 5.68 (2.77)
Citation Format: Yan Jiang, Zora Djuric, Jianwei Ren, Kuklev V. Dmitry, Austin Curtis, Gretchen S. Bentz, Ian Waters, Ananda Sen, Lili Zhao, Charis Uhlson, Robert Murphy, William L. Smith, Dean E. Brenner. Prostaglandin and associated eicosanoid dose response to omega-3 fatty acid (FA) diet in rat colon. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4863. doi:10.1158/1538-7445.AM2013-4863
Collapse
Affiliation(s)
- Yan Jiang
- 1Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Zora Djuric
- 2Department of Family Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Jianwei Ren
- 2Department of Family Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Kuklev V. Dmitry
- 3Department of Biological Chemistry, The University of Michigan Medical School, Ann Arbor, MI
| | - Austin Curtis
- 1Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Gretchen S. Bentz
- 1Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Ian Waters
- 1Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Ananda Sen
- 2Department of Family Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Lili Zhao
- 2Department of Family Medicine, The University of Michigan Medical School, Ann Arbor, MI
| | - Charis Uhlson
- 4Department of Pharmacology, University of Colorado, Aurora, CO
| | - Robert Murphy
- 4Department of Pharmacology, University of Colorado, Aurora, CO
| | - William L. Smith
- 3Department of Biological Chemistry, The University of Michigan Medical School, Ann Arbor, MI
| | - Dean E. Brenner
- 1Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI
| |
Collapse
|
39
|
Citronberg J, Bostick R, Ahearn T, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM. Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) 2013; 6:271-81. [PMID: 23303903 PMCID: PMC3618532 DOI: 10.1158/1940-6207.capr-12-0327] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
To estimate the effects of ginger on apoptosis, proliferation, and differentiation in the normal-appearing colonic mucosa, we randomized 20 people at increased risk for colorectal cancer to 2.0 g of ginger or placebo daily for 28 days in a pilot trial. Overall expression and distributions of Bax, Bcl-2, p21, hTERT, and MIB-1 (Ki-67) in colorectal crypts in rectal mucosa biopsies were measured using automated immunohistochemistry and quantitative image analysis. Relative to placebo, Bax expression in the ginger group decreased 15.6% (P = 0.78) in the whole crypts, 6.6% (P = 0.95) in the upper 40% (differentiation zone) of crypts, and 21.7% (P = 0.67) in the lower 60% (proliferative zone) of crypts; however, there was a 19% increase (P = 0.14) in Bax expression in the upper 40% relative to the whole crypt. While p21 and Bcl-2 expression remained relatively unchanged, hTERT expression in the whole crypts decreased by 41.2% (P = 0.05); the estimated treatment effect on hTERT expression was larger in the upper 40% of crypts (-47.9%; P = 0.04). In the ginger group, MIB-1 expression decreased in the whole crypts, upper 40% of crypts, and lower 60% of crypts by 16.9% (P = 0.39), 46.8% (P = 0.39), and 15.3% (P = 0.41), respectively. These pilot study results suggest that ginger may reduce proliferation in the normal-appearing colorectal epithelium and increase apoptosis and differentiation relative to proliferation--especially in the differentiation zone of the crypts and support a larger study to further investigate these results.
Collapse
Affiliation(s)
| | - Roberd Bostick
- Department of Epidemiology, Emory University, Atlanta, GA
- Winship Cancer Institute, Emory University, Atlanta, GA
| | - Thomas Ahearn
- Department of Epidemiology, Emory University, Atlanta, GA
| | - D. Kim Turgeon
- Department of Internal Medicine, University of Michigan Medical School
| | - Mack T. Ruffin
- Department of Family Medicine, University of Michigan Medical School
| | - Zora Djuric
- Department of Family Medicine, University of Michigan Medical School
| | - Ananda Sen
- Department of Family Medicine, University of Michigan Medical School
| | - Dean E. Brenner
- Department of Internal Medicine, University of Michigan Medical School
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI
- VA Medical Center, Ann Arbor, MI
| | - Suzanna M. Zick
- Department of Family Medicine, University of Michigan Medical School
| |
Collapse
|
40
|
Ramnath N, Daignault-Newton S, Dy GK, Muindi JR, Adjei A, Elingrod VL, Kalemkerian GP, Cease KB, Stella PJ, Brenner DE, Troeschel S, Johnson CS, Trump DL. A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 2013; 71:1173-82. [PMID: 23435876 DOI: 10.1007/s00280-013-2109-x] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2012] [Accepted: 02/04/2013] [Indexed: 12/20/2022]
Abstract
BACKGROUND Preclinical studies demonstrated antiproliferative synergy of 1,25-D3 (calcitriol) with cisplatin. The goals of this phase I/II study were to determine the recommended phase II dose (RP2D) of 1,25-D3 with cisplatin and docetaxel and its efficacy in metastatic non-small-cell lung cancer. METHODS Patients were ≥18 years, PS 0-1 with normal organ function. In the phase I portion, patients received escalating doses of 1,25-D3 intravenously every 21 days prior to docetaxel 75 mg/m(2) and cisplatin 75 mg/m(2) using standard 3 + 3 design, targeting dose-limiting toxicity (DLT) rate <33 %. Dose levels of 1,25-D3 were 30, 45, 60, and 80 mcg/m(2). A two-stage design was employed for phase II portion. We correlated CYP24A1 tagSNPs with clinical outcome and 1,25-D3 pharmacokinetics (PK). RESULTS 34 patients were enrolled. At 80 mcg/m(2), 2/4 patients had DLTs of grade 4 neutropenia. Hypercalcemia was not observed. The RP2D of 1,25-D3 was 60 mcg/m(2). Among 20 evaluable phase II patients, there were 2 confirmed, 4 unconfirmed partial responses (PR), and 9 stable disease (SD). Median time to progression was 5.8 months (95 % CI 3.4, 6.5), and median overall survival 8.7 months (95 % CI 7.6, 39.4). CYP24A1 SNP rs3787554 (C > T) correlated with disease progression (P = 0.03) and CYP24A1 SNP rs2762939 (C > G) trended toward PR/SD (P = 0.08). There was no association between 1,25-D3 PK and CYP24A1 SNPs. CONCLUSIONS The RP2D of 1,25-D3 with docetaxel and cisplatin was 60 mcg/m(2) every 21 days. Pre-specified endpoint of 50 % confirmed RR was not met in the phase II study. Functional SNPs in CYP24A1 may inform future studies individualizing 1,25-D3.
Collapse
Affiliation(s)
- N Ramnath
- Division of Medical Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Abstract
The challenges of clinical screening of cancer risk reductive interventions ("chemopreventive") have slowed progress in deployment of therapeutics to reverse or delay the carcinogenesis process. The preoperative or window-of-opportunity design clinical trial design enrolls subjects rapidly, has short study periods, and quantifies tissue biomarkers that reflect both anti-carcinogenesis mechanism of the risk reductive intervention and key molecular events of the carcinogenesis process for a specific epithelial target. High subject screened to on study ratios reduce the efficiency and increase cost of this research strategy. Small-sized tissue samples obtained by minimally invasive endoscopic technologies limit the number of biomarkers that can be detected and quantified, forcing investigators into choosing either a broad-based but superficial multi-mechanism exploration of signaling intermediates or a more focused analysis of multiple molecular events in a linear signaling-specific pathway. More efficient strategies of the future might involve isolation and expansion of pluripotent cells from at-risk epithelium or intraepithelial neoplastic lesions. Such a strategy would allow interrogation of key carcinogenesis-associated pathways and mechanisms in representative primary single-cell cultures amenable to genomic, proteomics, or transfection-based technologies.
Collapse
Affiliation(s)
- Dean E Brenner
- Departments of Internal Medicine and Pharmacology, University of Michigan, Ann Arbor, USA.
| | | |
Collapse
|
42
|
Djuric Z, Ruffin MT, Rapai ME, Cornellier ML, Ren J, Ferreri TG, Askew LM, Sen A, Brenner DE, Turgeon DK. A Mediterranean dietary intervention in persons at high risk of colon cancer: recruitment and retention to an intensive study requiring biopsies. Contemp Clin Trials 2012; 33:881-8. [PMID: 22640923 PMCID: PMC3408796 DOI: 10.1016/j.cct.2012.05.006] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2011] [Revised: 05/13/2012] [Accepted: 05/19/2012] [Indexed: 11/25/2022]
Abstract
This study recruited persons at increased risk of colon cancer to an intensive dietary intervention study that required biopsies of the colon by flexible sigmoidoscopy at baseline and after six months of intervention. A total of 1314 individuals contacted the study, and only 16 individuals indicated that the sigmoidoscopy procedure was an obstacle to study participation. A total of 270 individuals completed a screening visit and signed a screening consent form. Inquiries about the study tended to be fewer in the winter and late summer. Failure to return food records was the most common reason for exclusion. Dietary recall at enrollment indicated that subjects were consuming significantly more vegetables, lower sodium and a lower glycemic load on the day before starting the study vs. during the eligibility phase which might have an impact on biomarker measures. This makes it important to capture dietary changes in the period between determination of eligibility and enrollment. Subjects (n=120) were randomized to follow a Healthy Eating or a Mediterranean Diet, each of which required substantial dietary record-keeping. The study completion rate was 78%, and subjects reported high satisfaction with study participation. Of the 93 individuals who completed the study, only one refused the flexible sigmoidoscopy at the final visit. These findings suggest that flexible sigmoidoscopy does not appear to be a barrier for recruitment of high-risk individuals to an intensive dietary intervention trial, but that completing food records can be.
Collapse
Affiliation(s)
- Zora Djuric
- Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
|
44
|
Ramnath N, Daignault-Newton S, Dy GK, Muindi J, Adjei A, Kalemkerian GP, Cease KB, Stella PJ, Brenner DE, Johnson CS, Trump DL. A phase I/II clinical trial of intravenous (I.V.) calcitriol with fixed doses of cisplatin and docetaxel in advanced non-small cell lung cancer. J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.e18118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e18118 Background: In vitro and in vivo studies have demonstrated the antiproliferative effects of 1, 25 (OH)2D3 (calcitriol) as single agent and antitumor synergy with cisplatin. The goals of this Phase I/II study were to determine the maximum tolerated dose (MTD) of 1, 25 (OH)2 D3 in combination with cisplatin and docetaxel, and to evaluate the efficacy in patients (pts) with metastatic NSCLC.Methods: The study was a multicenter, open-label study in pts with metastatic NSCLC. Pts were adults 18 yrs., PS 0-1 with normal liver/kidney function. For the phase I study, pts (3–6 per cohort) received 1, 25 (OH)2 D3 I.V. every 21 days prior to docetaxel and cisplatin. The starting dose of 1,25 (OH)2D3 was 15 mcg/m2 at sequential ascending dose levels (DL) (15, 30, 60 and 80 mcg/m2) using a 3+3 design targeting a dose-limiting toxicity (DLT) rate of <33%. Docetaxel was administered at 75 mg/m2 and cisplatin 75mg/m2 following 1, 25 (OH)2 D3 for 4 cycles. We analyzed SNPs in the CYP24A1 gene.Results: 37 pts were enrolled (16 in phase I and 21 in phase II) with a median age of 54 (range 34–79) yrs.; M: F, 12:17. At the 80 mcg/m2 dose level, 2/4 pts had DLT of grade 4 neutropenia. There were no cases of hypercalcemia or azotemia. The MTD and recommended Phase II dose was 60 mcg/m2. Among 6 response-evaluable Phase I pts, and 21 phase II pts, there were: 2 confirmed partial responses (PR), 6 unconfirmed PRs and 10 pts with stable disease. The median time to progression was 6.9 months (95% CI 4.4, 12.9) and the median overall survival was 8.3 months (95% CI 5.8, 14.9). Of the CYP24A1 SNPs, the IVS4-308C>G was associated with progressive disease (Chi-Square=0.0062)Conclusions: The MTD of 1,25 (OH)2D3 in combination with docetaxel and cisplatin was 60 mcg/m2 IV every 21 days. Pre-specified endpoint of a 50% response rate was not met in the phase II study. However, disease control in 66% of patients argues for further study of 1,25 (OH)2D3 as maintenance therapy. The CYP24A1 polymorphism IVS4-308C>G may be associated with resistance to a 1,25 (OH)2D3 based therapeutic regimen
Collapse
Affiliation(s)
- Nithya Ramnath
- University of Michigan Comprehensive Cancer Center and the Ann Arbor Veterans Administration Medical Center, Ann Arbor, MI
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Kim SH, Chen G, King AN, Jeon CK, Christensen PJ, Zhao L, Simpson RU, Thomas DG, Giordano TJ, Brenner DE, Hollis B, Beer DG, Ramnath N. Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung Cancer 2012; 77:265-71. [PMID: 22564539 DOI: 10.1016/j.lungcan.2012.04.010] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2011] [Revised: 02/23/2012] [Accepted: 04/12/2012] [Indexed: 01/01/2023]
Abstract
PURPOSE The anti-proliferative effects of 1α,25-dihydroxyvitamin D(3) (1,25-D(3), calcitriol, the active form of vitamin D) are mediated by the nuclear vitamin D receptor (VDR). In the present study, we characterized VDR expression in lung adenocarcinoma (AC). EXPERIMENTAL DESIGN We examined VDR mRNA expression using a quantitative real-time PCR (qRT-PCR) in 100 patients who underwent surgery for lung AC. In a subset of these patients (n=89), we examined VDR protein expression using immunohistochemistry. We also examined the association of VDR protein expression with circulating serum levels of 25-hydroxyvitamin D(3) (25-D(3)) and 1,25-D(3). The antiproliferative effects and cell cycle arrest of 1,25-D(3) were examined using lung cancer cell lines with high (SKLU-1) as well as low (A549) expression of VDR mRNA. RESULTS Higher VDR expression correlates with longer survival after adjusting for age, sex, disease stage and tumor grade (HR 0.73, 95% CI 0.58-0.91). In addition, there was a positive correlation (r=0.38) between serum 1,25-D(3) and tumor VDR protein expression. A greater anti-proliferative effect of 1,25-D(3) was observed in high compared to low VDR-expressing cell lines; these effects corresponded to G1 cell cycle arrest; this was associated with a decline in cyclin D1, S-phase kinase protein 2 (Skp2), retinoblastoma (Rb) and minichromosome maintenance 2 (MCM2) proteins involved in S-phase entry. CONCLUSIONS Increased VDR expression in lung AC is associated with improved survival. This may relate to a lower proliferative status and G1 arrest in high VDR-expressing tumors.
Collapse
Affiliation(s)
- So Hee Kim
- Division of Medical Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Jiang Y, Ren J, Waters I, Smith WL, Brenner DE. Abstract 1635: Effect of dietary fish oil on rat colonic prostaglandin (PG) E2 metabolism. Cancer Res 2012. [DOI: 10.1158/1538-7445.am2012-1635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
PGE2, an eicosanoid generated from arachidonic acid (AA) by the cyclooxygenase function of prostaglandin H synthases (PGHS)-1 and 2, has been linked to the risk of many cancers including colorectal carcinogenesis. Targeting colonic PGE2 homeostasis by utilizing nutritional products such as fish oil may reduce endogenous PGE2 that, in turn, may decrease subsequent inflammatory events that lead to carcinogenesis. Rats were fed high fat fish oil diets contained different ratios of eicosapentaenoic acid (EPA) and n-6 fatty acid. The colon was horizontally divided into three equal length transections, first (proximal end), second (transverse) and third (distal end). Enzymes involved in PGE2 metabolism (15-hydroxyprostaglandin dehydrogenase (15-PGDH) and PGE synthase (mPGES)) were measured using quantitative PCR and semi-quantitative Western Blotting. GC-MS analysis was performed to detect fatty acid levels in serum and colon. LC-MS/MS analysis was used to examine eicosanoid levels. Our results showed that the colonic epithelial mucosa contained less PGE2 per mg of protein than did the whole colon. Colonic PGE2 and several eicosanoids including 13-Hydroxyoctadecadienoic acid(13HODE), 5-Hydroxyeico-satetraenoic acid (5 HETE), 15-Hydroxyeicosatetraenoic acid (15 HETE) and 12-Hydroxyeicosatetraenoic acid (12 HETE) were distributed differentially in different part of the colon. Dietary fish oil intake increased tissue levels of EPA in the colon. PGHS-2 gene was affected the most by dietary fish oil among all the genes tested in normal colon. Fish oil dose-dependently decreased PGHS-2 mRNA expression in all three colon sections. mRNA expression of 15-PGDH was higher in the third colonic section than the first two sections; however it was not altered by dietary fish oil. In conclusion, different parts of the colon have different eicosanoid profiles. The decreases in PGE2 in normal colon observed with fish oil feeding do not appear to be related to expression of PGHS-1, mPGES and 15-PGDH but are most closely correlated with PGHS-2 despite that PGHS-2 levels are already low in the normal colon. These data support the concept of anatomic variability in colonic carcinogenesis.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1635. doi:1538-7445.AM2012-1635
Collapse
Affiliation(s)
- Yan Jiang
- 1University of Michigan, Ann Arbor, MI
| | | | | | | | | |
Collapse
|
47
|
Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res (Phila) 2012; 5:655-64. [PMID: 22277732 DOI: 10.1158/1940-6207.capr-11-0412] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Longitudinal blood collections from cohort studies provide the means to search for proteins associated with disease before clinical diagnosis. We investigated plasma samples from the Women's Health Initiative (WHI) cohort to determine quantitative differences in plasma proteins between subjects subsequently diagnosed with colorectal cancer (CRC) and matched controls that remained cancer-free during the period of follow-up. Proteomic analysis of WHI samples collected before diagnosis of CRC resulted in the identification of six proteins with significantly (P < 0.05) elevated concentrations in cases compared with controls. Proteomic analysis of two CRC cell lines showed that five of the six proteins were produced by cancer cells. Microtubule-associated protein RP/EB family member 1 (MAPRE1), insulin-like growth factor-binding protein 2 (IGFBP2), leucine-rich alpha-2-glycoprotein (LRG1), and carcinoembryonic antigen (CEA) were individually assayed by enzyme linked immunosorbent assay (ELISA) in 58 pairs of newly diagnosed CRC samples and controls and yielded significant elevations (P < 0.05) among cases relative to controls. A combination of these four markers resulted in a receiver operating characteristics curve with an area under the curve value of 0.841 and 57% sensitivity at 95% specificity. This combination rule was tested in an independent set of WHI samples collected within 7 months before diagnosis from cases and matched controls resulting in 41% sensitivity at 95% specificity. A panel consisting of CEA, MAPRE1, IGFBP2, and LRG1 has predictive value in prediagnostic CRC plasmas.
Collapse
Affiliation(s)
- Jon J Ladd
- Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Yurgelun MB, Goel A, Hornick JL, Sen A, Turgeon DK, Ruffin MT, Marcon NE, Baron JA, Bresalier RS, Syngal S, Brenner DE, Boland CR, Stoffel EM. Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) 2012; 5:574-82. [PMID: 22262812 DOI: 10.1158/1940-6207.capr-11-0519] [Citation(s) in RCA: 85] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Colorectal cancers associated with Lynch syndrome are characterized by deficient DNA mismatch repair (MMR) function. Our aim was to evaluate the prevalence of microsatellite instability (MSI) and loss of MMR protein expression in Lynch syndrome-associated polyps. Sixty-two colorectal polyps--37 adenomatous polyps, 23 hyperplastic polyps, and 2 sessile serrated polyps (SSP)--from 34 subjects with germline MMR gene mutations were tested for MSI using a single pentaplex PCR for five mononucleotide repeat microsatellite markers, and also for expression of MLH1, MSH2, MSH6, and PMS2 proteins by immunohistochemistry. High-level MSI (MSI-H) was seen in 15 of 37 (41%) adenomatous polyps, one of 23 (4%) hyperplastic polyps, and one of two (50%) SSPs. Loss of MMR protein expression was seen in 18 of 36 (50%) adenomatous polyps, zero of 21 hyperplastic polyps, and zero of two SSPs. Adenomatous polyps 8 mm or larger in size were significantly more likely to show MSI-H [OR, 9.98; 95% confidence interval (CI), 1.52-65.65; P = 0.02] and deficient MMR protein expression (OR, 3.17; 95% CI, 1.20-8.37; P = 0.02) compared with those less than 8 mm in size. All (six of six) adenomatous polyps 10 mm or larger in size showed both MSI-H and loss of MMR protein expression by immunohistochemistry. Our finding that the prevalence of MMR deficiency increases with the size of adenomatous polyps suggests that loss of MMR function is a late event in Lynch syndrome-associated colorectal neoplasia. Although testing large adenomatous polyps may be of value in the diagnostic evaluation of patients with suspected Lynch syndrome, the absence of an MMR-deficient phenotype in an adenoma cannot be considered as a strong evidence against Lynch syndrome, as it is with colorectal carcinomas.
Collapse
|
49
|
Song BP, Jain S, Lin SY, Chen Q, Block TM, Song W, Brenner DE, Su YH. Detection of hypermethylated vimentin in urine of patients with colorectal cancer. J Mol Diagn 2012; 14:112-9. [PMID: 22251609 DOI: 10.1016/j.jmoldx.2011.12.003] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2011] [Revised: 12/01/2011] [Accepted: 12/07/2011] [Indexed: 02/06/2023] Open
Abstract
We demonstrated previously that urine contains low-molecular-weight (LMW) (<300 bp), circulation-derived DNA that can be used to detect cancer-specific mutations if a tumor is present. The goal of this study was to develop an assay to detect the colorectal cancer (CRC)-associated, circulation-derived, epigenetic DNA marker hypermethylated vimentin gene (mVIM) in the urine of patients with CRC. An artificial 18-nucleotide DNA sequence was tagged at the 5' end of the primers of the first PCR cycle to increase the amplicon size, which was then integrated into the primers of the second PCR cycle. A quantitative MethyLight PCR-based assay targeting a 39-nucleotide template was developed and used to quantify mVIM in CRC tissues and matched urine samples. mVIM was detected in 75% of LMW urine DNA samples from patients with CRC (n = 20) and in 10% of urine samples of control subjects with no known neoplasia (n = 20); 12 of 17 LMW urine DNA samples (71%) but only 2 of 17 high-molecular-weight urine DNA samples (12%) from patients with mVIM-positive tissues contained detectable mVIM, suggesting that the mVIM detected in LMW urine DNA is derived from the circulation. The detection of mVIM in urine was significantly associated with CRC compared with controls (P < 0.0001, by Fisher's exact test). A potential urine test for CRC screening using epigenetic markers is discussed.
Collapse
Affiliation(s)
- Benjamin P Song
- Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 18901, USA
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Yue T, Maupin KA, Fallon B, Li L, Partyka K, Anderson MA, Brenner DE, Kaul K, Zeh H, Moser AJ, Simeone DM, Feng Z, Brand RE, Haab BB. Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PLoS One 2011; 6:e29180. [PMID: 22220206 PMCID: PMC3248411 DOI: 10.1371/journal.pone.0029180] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2010] [Accepted: 11/22/2011] [Indexed: 12/21/2022] Open
Abstract
The CA 19-9 assay detects a carbohydrate antigen on multiple protein carriers, some of which may be preferential carriers of the antigen in cancer. We tested the hypothesis that the measurement of the CA 19-9 antigen on individual proteins could improve performance over the standard CA 19-9 assay. We used antibody arrays to measure the levels of the CA 19-9 antigen on multiple proteins in serum or plasma samples from patients with pancreatic adenocarcinoma or pancreatitis. Sample sets from three different institutions were examined, comprising 531 individual samples. The measurement of the CA 19-9 antigen on any individual protein did not improve upon the performance of the standard CA 19-9 assay (82% sensitivity at 75% specificity for early-stage cancer), owing to diversity among patients in their CA 19-9 protein carriers. However, a subset of cancer patients with no elevation in the standard CA 19-9 assay showed elevations of the CA 19-9 antigen specifically on the proteins MUC5AC or MUC16 in all sample sets. By combining measurements of the standard CA 19-9 assay with detection of CA 19-9 on MUC5AC and MUC16, the sensitivity of cancer detection was improved relative to CA 19-9 alone in each sample set, achieving 67–80% sensitivity at 98% specificity. This finding demonstrates the value of measuring glycans on specific proteins for improving biomarker performance. Diagnostic tests with improved sensitivity for detecting pancreatic cancer could have important applications for improving the treatment and management of patients suffering from this disease.
Collapse
Affiliation(s)
- Tingting Yue
- Laboratory of Cancer Immunodiagnostics, Van Andel Institute, Grand Rapids, Michigan, United States of America
- Cell and Molecular Biology Program, Michigan State University, East Lansing, Michigan, United States of America
| | - Kevin A. Maupin
- Laboratory of Cancer Immunodiagnostics, Van Andel Institute, Grand Rapids, Michigan, United States of America
| | - Brian Fallon
- Laboratory of Cancer Immunodiagnostics, Van Andel Institute, Grand Rapids, Michigan, United States of America
| | - Lin Li
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
| | - Katie Partyka
- Laboratory of Cancer Immunodiagnostics, Van Andel Institute, Grand Rapids, Michigan, United States of America
| | - Michelle A. Anderson
- University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
| | - Dean E. Brenner
- University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
| | - Karen Kaul
- Northshore University Health System, Evanston, Illinois, United States of America
| | - Herbert Zeh
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America
| | - A. James Moser
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America
| | - Diane M. Simeone
- University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
| | - Ziding Feng
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
| | - Randall E. Brand
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America
| | - Brian B. Haab
- Laboratory of Cancer Immunodiagnostics, Van Andel Institute, Grand Rapids, Michigan, United States of America
- * E-mail:
| |
Collapse
|